0000000000521508

AUTHOR

Maria Rita Bongiorno

showing 165 related works from this author

Possible strategy to prevent recurrence of actinic keratosis after treatment field-direct.

2020

actinic keratosis piroxicam treatmentmedicine.medical_specialtyKeratosisbusiness.industryActinic keratosisDermatologyGeneral MedicinePiroxicammedicine.diseaseDermatologyKeratosis ActinicNeoplasm RecurrencemedicineHumansNeoplasm Recurrence LocalbusinessAfter treatmentmedicine.drugDermatologic therapy
researchProduct

Incidence of onychomycosis among psoriatic patients with nail involvement: a descriptive study

2013

AdultMalemedicine.medical_specialtyAdolescentMEDLINEonychomycosis PSORIASIS NAILSDermatologyYoung AdultOnychomycosisHumansPsoriasisMedicineYoung adultAgedbusiness.industryIncidenceIncidence (epidemiology)General MedicineMiddle AgedDermatologyInfectious Diseasesmedicine.anatomical_structureNailsNail (anatomy)FemaleDescriptive researchbusinessMycoses
researchProduct

Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice

2016

Chronic spontaneous urticaria (CSU) is a skin disease that predominantly affects adults, especially women aged 20 to 40 years, and is characterized by the recurrent appearance of localized or widespread wheals, angioedema or both, without apparent external trigger. 1 , 2 Severe CSU has a detrimental effect on the quality of life and is a frequent cause of absenteeism from school and work. [3] The pathogenesis of CSU is not well understood, and it appears to have an autoimmune cause in approximately one-third of patients. [4] Guidelines for the management of CSU recommend the use of second-generation antihistamines, with the addition of leukotriene receptor antagonists, cyclosporine, or omal…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyUrticariabusiness.industryImmunologyMEDLINEOmalizumabOmalizumabDermatologyClinical PracticeAnti-Allergic Agents; Chronic Disease; Humans; Omalizumab; Urticaria; Immunology and Allergy; Pulmonary and Respiratory Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChronic disease030228 respiratory systemAnti-Allergic AgentsChronic DiseaseHumansMedicineImmunology and AllergybusinessAnti-Allergic Agentsmedicine.drug
researchProduct

Letter: psoriasiform eruption during vedolizumab therapy

2019

medicine.medical_specialtyHepatologybusiness.industryGastroenterologyInflammatory Bowel DiseasesAntibodies Monoclonal HumanizedInflammatory Bowel Diseasesmedicine.diseaseDermatologyVedolizumabPsoriasiform eruptionPsoriasisMonoclonalHumansPsoriasisMedicinePharmacology (medical)Registriespsoriasiform eruption vedolizumabbusinessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Rituximab in refractory pemphigus vulgaris

2008

Pemphigus vulgaris (PV) is a severe chronic autoimmune blistering disease of skin and mucous membranes. The use of systemic corticosteroids in pemphigus has dramatically reduced its mortality rate, but the long-term use of steroids leads to severe side effects, many of which are serious. For this reason it is often necessary to add immunosuppressive agents to the regimen. However, there are occasional refractory cases in which therapy with conventionally accepted modalities is either not efficacious or not possible on account of side effects. Rituximab is a therapeutic monoclonal antibody targeting CD20, an integral membrane protein highly expressed on the surface of pre-B lymphocytes and a…

Adultmedicine.medical_specialtyAntigens CD19B-Lymphocyte SubsetsDrug ResistanceDermatologyDrug Administration ScheduleAntibodies Monoclonal Murine-DerivedPharmacotherapyRefractoryRituximab pemphigus vulgarisimmune system diseasesHumansImmunologic FactorsMedicineInfusions IntravenousCD20integumentary systembiologybusiness.industryRemission InductionPemphigus vulgarisAntibodies MonoclonalGeneral MedicineAntigens CD20medicine.diseaseDermatologyRegimenPemphigusMonoclonalImmunologybiology.proteinPrednisoneDrug Therapy CombinationFemaleRituximabRituximabbusinessImmunosuppressive AgentsPemphigusmedicine.drugDermatologic Therapy
researchProduct

Transfusion-associated graft-versus-host disease-report of two further cases with an immunohistochemical analysis

1994

Summary Transfusion-associated graft-vs.-host disease (tGVHD) is a severe disease usually affecting immunocompromised hosts with haematological neoplasia. Two patients with acute leukaemia are reported, who developed fatal tGVHD after blood transfusions. Intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and endothelial leucocyte adhesion molecule 1 (ELAM-1) expression and the CD4/CD8 ratio were assessed in lesional skin. ICAM-1 was strongly expressed on epidermal keratinocytes and endothelial cells (EC) and correlated with HLA-DR staining. VCAM-1 was strongly expressed on EC in the superficial dermal vessels. ELAM-1 stained weakly on EC in some of the su…

Pathologymedicine.medical_specialtyBlood transfusionCD3medicine.medical_treatmentIntercellular Adhesion Molecule-1CD4-CD8 RatioGraft vs Host DiseaseVascular Cell Adhesion Molecule-1CD18DermatologyTransfusion-associated graft versus host diseaseFatal OutcomeHumansLeukemia-Lymphoma Adult T-CellMedicineSkinbiologybusiness.industryCell adhesion moleculeTransfusion ReactionMiddle AgedIntercellular Adhesion Molecule-1medicine.diseaseLeukemia Myeloid AcuteLeukemiaImmunologybiology.proteinFemalebusinessCell Adhesion MoleculesCD8Clinical and Experimental Dermatology
researchProduct

Some genotypic and environmental conditions of the host in cutaneous malignant melanoma

2006

The factors involving the development of melanoma vary according to the phenotype and environment conditions experienced by the host MC1R variant alleles that are associated with increased melanoma risk are likely to sensitize melanocytes to DNA damage by ultraviolet (UV) exposure, and the interactions between UV radiation and the genome induce melanoma. In fact, the non-functional MC1R cells have a very slow rate of cyclobutane pyrimidine dimers removal. The most significant mutations induced by UV in the skin occur in the CDKN2A gene being the major target of UV, that encodes 2 distinct proteins cell cycle regulators: p16INK4A and p14ARF. Inactivation of both tumor suppressors results in …

Utraviolet raysEnvironmentMelanoma
researchProduct

Multiple Cutaneous Metastases in the Chest from Prostatic Carcinoma

2013

We report a case of multiple cutaneous metastases from prostate cancer. A 78-year-old man with an 8-year history of prostate cancer had multiple nodular lesions in the chest. Histologically, the lesion showed an abortive glandular lumina and tall columnar cells with abundant cytoplasm. Immunohistochemical staining for AE1:AE3 cytokeratin cocktail, prostate-specific antigen, and prostate-specific acid phosphatase was positive in tumor cells, confirming the diagnosis of cutaneous metastases from prostate cancer. We report this case because of the rarity of cutaneous metastases from prostatic adenocarcinoma in the chest region.

PCA3Pathologymedicine.medical_specialtyCutaneous metastases · Prostatic carcinoma · AE1:AE3 cytokeratin · Prostate-specific antigen · Prostate-specific acid phosphataseDermatologyPublished online: May 2013Prostatic carcinomaLesionProstate cancerCytokeratinAntigenlcsh:DermatologySettore MED/35 - Malattie Cutanee E VenereeCarcinomaMedicineAE1:AE3 cytokeratinProstate-specific acid phosphatasebusiness.industrylcsh:RL1-803Cutaneous metastasesmedicine.diseaseProstate-specific antigenProstate-specific antigenImmunohistochemistrymedicine.symptombusinessCase Reports in Dermatology
researchProduct

The prevalence of the obesity in patients with moderate to severe psoriasis in Sicily populations

2010

medicine.medical_specialtyLipid Metabolism Disorderbusiness.industryBlood lipidsDermatologyOverweightmedicine.diseaseObesityInfectious DiseasesEndocrinologyPsoriasisDiabetes mellitusInternal medicinemedicinemedicine.symptomMetabolic syndromebusinessBody mass indexJournal of the European Academy of Dermatology and Venereology
researchProduct

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet (R)) versus calcipotriol (Daivonex (R)) in the treatment of …

2007

Objective: A clinical trial was performed to evaluate the efficacy, speed of response, side effects and quality of life of patients treated with calcipotriol/betamethasone dipropionate (Dovobet (R)) for 4 weeks followed by maintenance with calcipotriol for 8 weeks (group A) versus calcipotriol (Daivonex (R)) alone for 12 weeks (group B) for the treatment of psoriasis. Materials and methods: A total of 150 patients were enrolled and randomized to groups A and B. PASI and Skindex-29 were considered the outcome measures. Results: Ninety-six patients completed the trial. At weeks 2 and 4, both groups showed a significant clinical improvement compared to baseline; group A demonstrated a higher c…

AdultMalemedicine.medical_specialtyRandomizationAdolescentskindex-29medicine.drug_classBetamethasone dipropionatecalcipotriol/betamethasone dipropionate; Dovobet; calcipotriol. Daivonex; psoriasis vulgaris; clinical trialDermatologyAdministration CutaneousBetamethasoneSeverity of Illness IndexDrug Administration Schedulelaw.inventionchemistry.chemical_compoundRandomized controlled trialCalcitriolcalcipotriolo/betametasone dipropionatolawPsoriasisInternal medicinepasimedicineHumansPsoriasiscalcipotriolo; calcipotriolo/betametasone dipropionato; pasi; psoriasi; skindex-29CalcipotriolcalcipotriolopsoriasiAgedAged 80 and overAnalysis of Variancebusiness.industrycalcipotriol calcipotriol/betamethasone dipropionate PASI psoriasis Skindex-29 two-compound productMiddle Agedmedicine.diseaseSurgeryClinical trialDrug CombinationsTreatment OutcomechemistryQuality of LifeCorticosteroidBetamethasoneFemaleDermatologic Agentsbusinessmedicine.drug
researchProduct

Adherence to biological therapy in dermatological patients during the COVID‐19 pandemic in Western Sicily

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySkin DiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19DermatologySkin DiseasesVirologyMedication AdherenceBiological TherapyCommunicable Disease ControlEpidemiologyPandemicmedicineHumansbusinessSicilyHumanInternational Journal of Dermatology
researchProduct

Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study

2020

Background: Cyclosporine A (CsA) is one of the systemic therapeutic options for moderate-to-severe psoriasis, based on its efficacy and rapidity of action. The current study investigated the response to CsA in patients with moderate-to-severe plaque psoriasis. Materials and Methods: TRANSITION was an observational, cross-sectional, multicentre study which evaluated the proportion of partial- and suboptimal-responders among patients with moderate-to-severe plaque psoriasis treated with continuous CsA for >= 12 weeks. Patients demonstrating a Psoriasis Area and Severity Index (PASI) response of >= 90, >= 75 and <90, >= 50 and <75 and <50 were defined as responders, subopt…

Moderate to severeMalemedicine.medical_specialtysystemic therapy.macromolecular substancesDermatologySystemic therapySeverity of Illness Indexsystemic therapy030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePsoriasisMedicineHumansPsoriasisIn patientPASI; cyclosporine A; moderate to severe plaque psoriasis; systemic therapy030203 arthritis & rheumatologyPlaque psoriasisbusiness.industryPASIMiddle Agedmedicine.diseasemoderate to severe plaque psoriasiDermatologycyclosporine A; moderate to severe plaque psoriasis; PASI; systemic therapyCross-Sectional StudiesTreatment OutcomeCyclosporineQuality of LifeFemalebusinesscyclosporine Amoderate to severe plaque psoriasis
researchProduct

Amelanotic conjunctival melanoma

2006

Conjunctival melanoma is a rare condition of the eye pigment predominantly affecting white adults. We describe a 32-year-old white man with an amelanotic malignant melanoma of the conjunctiva that is not associated with primary acquired melanosis (PAM) or melanocytic nevus. The patient presented with a 2-year history of nonpigmented vascularized nodules of the right eye. Results of hematoxylin and eosin (H and E) staining of the lesion showed an invasive nodule with vertical spreading, invasion of the substantia propria corneae, and ulceration. S100 protein was expressed in the cells of the invasive nodule. HMB45 protein was highly positive in the melanoma cells. The de novo amelanotic mali…

AdultMaleConjunctival melanomaprimary acquired melanosis (PAM).HumansConjunctival NeoplasmsMelanoma AmelanoticConjunctivaImmunohistochemistryamelanotic malignant melanoma
researchProduct

Norwegian (crusted) scabies of glans penis in an immunocompetent patient

2009

medicine.medical_specialtybusiness.industryGlans penisDermatologyNorwegianCrusted scabiesmedicine.diseaseDermatologyNorwegian scabieslanguage.human_languageSurgeryParasitic skin diseasesmedicine.anatomical_structureScabiesmedicinelanguagebusinessSkin lesionPenisBritish Journal of Dermatology
researchProduct

Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients

2013

Adverse drug reactions to highly antiretroviral therapy (HAART) are major obstacles in its success. Although overall mortality from HIV has dramatically declined owing to HAART, these antiretroviral regimens have been associated with a wide spectrum of severe cutaneous reactions. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. To optimize adherence and efficacy of antiretroviral treatment, clinicians must focus on preventing adverse effects whenever possible, and distinguish those that are self-limited from those that are potentially serious. This paper presents the case of a serious cutaneous adverse reaction to Atripla in a HIV-positive 50-…

medicine.medical_specialtybusiness.industryHuman immunodeficiency virus (HIV)Adverse drug reactionAdverse drug reactionsHIVDermatologylcsh:RL1-803medicine.disease_causeAntiretroviral therapyPublished online: May 2014Surgerylcsh:DermatologymedicineAntiretroviral treatmentSettore MED/35 - Malattie Cutanee E VenereeDrug reactionIntensive care medicinebusinessAdverse effectHighly antiretroviral therapySkin
researchProduct

Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis.

2008

:  We present the case of a woman with diabetes insipidus with subsequent genital and multiorgan Langerhans cell histiocytosis (LCH). A monolateral and slightly infiltrated erythematous plaque of the vulva was observed. Hematoxylin and eosin and immunophenotypic studies were performed. The primary antibodies used were monoclonal antibody to S100, CD1a, CD34, HLA-DR, PCNA, CD45Ro, CD40, and langerin. The histology of the infiltrates revealed a granulomatous reaction pattern, with extensive aggregates of histiocyte proliferation. The histiocytes, morphologically characterized by a pale staining of cytoplasm surrounding a grooved reniform nucleus, sometimes contained small distinct nucleoli. L…

AdultPathologymedicine.medical_specialtyCell typeLangerhans cellLangerinDermatologyVinblastineMethylprednisoloneImmunophenotypingVulvaLangerhans cell histiocytosisErythematous plaqueSettore MED/35 - Malattie Cutanee E VenereemedicineHumansHistiocyteCD40integumentary systembiologyHistiocytesGeneral Medicinemedicine.diseaseImmunohistochemistryHistiocytosis Langerhans-Cellmedicine.anatomical_structureTreatment Outcomevulvar Langerhans cell histiocytosisGiant cellErythemaLangerhans Cellsbiology.proteinDrug Therapy CombinationFemaleDiabetes InsipidusDermatologic therapy
researchProduct

Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus

2010

Background  One of the major goals of pemphigus therapy is to reduce the patient’s cumulative exposure to systemic corticosteroids. To investigate the efficacy of enteric-coated mycophenolate sodium (EC-MPS), 10 patients with active, refractory pemphigus vulgaris (PV) or foliaceous (PF) were treated with EC-MPS (1440 mg daily) and prednisone (75 mg daily) over 18 months. Observations  Following EC-MPS/prednisone therapy, disease progression was inhibited between days 30 and 45 in 9/10 patients (8 PV; 1 PF). At 18 months, 8/9 PV patients had clinically quiescent disease; EC-MPS therapy was no longer required in two patients as a result of disease remission. The remaining PV patient showed no…

medicine.medical_specialtybusiness.industryPemphigus vulgarisMycophenolate SodiumAzathioprineDermatologymedicine.diseaseGastroenterologySurgeryPemphigusRefractoryPrednisoneInternal medicinemedicineAdjuvant therapyAdverse effectbusinessmedicine.drugInternational Journal of Dermatology
researchProduct

Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study

2021

BACKGROUND The anti-tumour necrosis factor (TNF)-α adalimumab is the only licenced biologic for moderate-to-severe hidradenitis suppurativa (HS). No predictors of response have been identified so far. OBJECTIVES To identify clinical parameters predicting response to adalimumab and confirm its efficacy/safety. METHODS The data of 389 patients with HS treated with adalimumab in 21 Italian centres were reviewed. Sex, age at onset/diagnosis/baseline, body mass index, smoking, phenotype, previous treatments, concomitant antibiotics and 'therapeutic delay', defined as the time from HS onset to adalimumab initiation, were assessed. Response to adalimumab and its impact on quality of life (QoL) wer…

medicine.medical_specialtyVisual analogue scaleAnti-Inflammatory AgentsDermatologySeverity of Illness Index030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSettore MED/35Quality of lifeInternal medicineSeverity of illnessmedicineAdalimumabHumansHidradenitis suppurativahidrosadenitis suppurativaRetrospective Studiesbusiness.industryAdalimumabRetrospective cohort studyOdds ratioDermatology Life Quality Indexmedicine.diseasehumanitiesHidradenitis SuppurativaTreatment OutcomeQuality of LifeAdalimumab Hidradenitis Suppurativa quality of lifeSettore MED/35 - MALATTIE CUTANEE E VENEREEbusinessmedicine.drug
researchProduct

Lack of antiandrogenic effects of topical bifonazole on sebaceous glands and hairs in the hamster flank organ.

1993

The activity of topically applied bifonazole was evaluated in vivo in the three androgen-dependent structures of the hamster flank organ, i.e. the pigmented spot, sebaceous glands and hairs. Topical bifonazole in our experience did not demonstrate any morphological effect on sebaceous gland and hair even when applied in the dosage of 3 mg/cm<sup>2</sup>/day. On the basis of our morphometric results we can conclude that topically applied bifonazole does not interfere with cutaneous androgen metabolic transformations in the pilosebaceous unit of the flank organ.

Sebaceous glandPathologymedicine.medical_specialtyFlankAntifungal AgentsPhysiologymedicine.drug_classAdministration TopicalBifonazoleHamsterDermatologyBiologyAntiandrogenSebaceous GlandsIn vivoInternal medicineCricetinaemedicineAnimalsPharmacologyMesocricetusPigmentationImidazolesAndrogen AntagonistsGeneral MedicineAndrogenbiology.organism_classificationmedicine.anatomical_structureEndocrinologyFemaleCabellomedicine.drugHairSkin pharmacology : the official journal of the Skin Pharmacology Society
researchProduct

Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment

2021

Despite the recent advances in cancer patient management and in the development of targeted therapies, systemic chemotherapy is currently used as a first-line treatment for many cancer types. After an initial partial response, patients become refractory to standard therapy fostering rapid tumor progression. Compelling evidence highlights that the resistance to chemotherapeutic regimens is a peculiarity of a subpopulation of cancer cells within tumor mass, known as cancer stem cells (CSCs). This cellular compartment is endowed with tumor-initiating and metastasis formation capabilities. CSC chemoresistance is sustained by a plethora of grow factors and cytokines released by neighboring tumor…

cancer stem cells0301 basic medicineCancer ResearchDNA repairmedicine.medical_treatmentReviewTargeted therapy03 medical and health sciences0302 clinical medicineImmune systemCancer stem celltumor microenvironmentMedicinecancer stem cells tumor microenvironment anticancer drugs chemoresistance targeted therapyRC254-282Tumor microenvironmentbusiness.industrychemoresistanceNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancertargeted therapymedicine.diseaseanticancer drugs030104 developmental biologyOncologyTumor progression030220 oncology & carcinogenesisCancer cellCancer researchSettore MED/46 - Scienze Tecniche Di Medicina Di Laboratoriobusiness
researchProduct

Plexiform Atypical Spitz Tumor With Rosette-Like Giant Cells. A Histologic and Immunohistochemical Study on a Case Suggesting Ganglioneuroblastic Dif…

2018

Spitz nevi, atypical Spitz tumors and Spitzoid melanoma, the three clinicopathologic forms that constitute the spectrum of the Spitz-type melanocytic lesions, share a histologic picture characterized by large spindle and/or epithelioid ganglion-like cells, with various admixtures of multinucleate bizarre cells. This remarkable cytology has always been interpreted as an unusual, as well as unexplained form of atypia. We report a case of atypical Spitz tumor with Homer Wright-like rosettes, a feature characteristic of ganglioneuroblastic proliferation. Furthermore, the ganglion-like cells of the tumor showed basophilic punctuation in the cytoplasm, reminiscent of Nissl substance, and a few ce…

Pathologymedicine.medical_specialtySkin NeoplasmsAdolescentCellular differentiationDermatologyHistogenesisBiologyGiant CellsPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineNevus Epithelioid and Spindle CellBiomarkers TumormedicineAtypiaSettore MED/35 - Malattie Cutanee E VenereeHumansNevusSpitz tumors Homer Wright–like rosettes ganglionlike cells ganglioneuroblastic differentiationGanglioneuromaGanglioneuroblastomaNeural crestCell DifferentiationGeneral Medicinemedicine.diseaseImmunohistochemistryGiant cell030220 oncology & carcinogenesisFemale
researchProduct

Pseudochromhidrosis: the role of dermoscopy in diagnosis

2014

medicine.medical_specialtybusiness.industryPseudochromhidrosisSettore MED/35 - Malattie Cutanee E VenereemedicineDermatologybusinessDermatologyPseudochromhidrosisInternational Journal of Dermatology
researchProduct

Fabry disease: enzyme replacement therapy

2003

Fabry disease is a multisystem disorder associated with wide variability in clinical expression. Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of alpha-galactosidase A. The enzyme defect leads to the systemic accumulation of glycosphingolipids with alpha-galactosyl moieties consisting predominantly of globotriaosylceramide, galabiosylceramide and two additional glycosphingolipids. Four hemizygotes patients with a family history of Fabry disease and deficiency of the enzyme alpha-galactosidase A were selected. Each patient received purified alpha-galactosidase by intravenous infusion (0.2 mg/kg). The infusion was administered every 2 weeks, for 40 min, for a …

Malemedicine.medical_specialtyGlobotriaosylceramideRenal functionVasomotionCorneal dystrophyDermatologyRisk AssessmentGastroenterologyDrug Administration ScheduleSampling Studieschemistry.chemical_compoundInternal medicineHumansMedicineFamily historyInfusions IntravenousDose-Response Relationship Drugbusiness.industryBiopsy NeedleOutcome measuresEnzyme replacement therapymedicine.diseaseImmunohistochemistryFabry diseaseTreatment OutcomeInfectious DiseasesEndocrinologychemistryalpha-GalactosidaseFabry DiseaseFemalebusinessFollow-Up StudiesJournal of the European Academy of Dermatology and Venereology
researchProduct

Identification of progenitor cancer stem cell in lentigo maligna melanoma.

2008

:  The potential role of stem cells in neoplasia has aroused considerable interest over the past few years. A number of known biologic characteristics of melanomas support the theory that they may originate in a mutated stem cell. Melanocytic stem cell markers have been described recently. Moreover, the CD133 cells that show surface markers for CD34 are stem cells primitive. These stem cells are capable of differentiating into neurons, glia, keratinocytes, smooth muscle cells, and melanocytes in vitro. The identification of cancer stem/initiating cells with a crucial role in tumor formation may open up new pharmacologic perspectives. The purpose of this study is to detect the expression of …

Pathologymedicine.medical_specialtySkin NeoplasmsCD34Antigens CD34DermatologyBiologyStem cell markerHutchinson's Melanotic FreckleCancer stem cellAntigens CDMelanoblastmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansAC133 AntigenLentigo maligna melanomaGlycoproteinsMelanomaGeneral Medicinemedicine.diseasecancer stem cell lentigo maligna melanomaNeoplastic Stem CellsMelanocytesStem cellPeptidesHair FollicleBiomarkersAdult stem cell
researchProduct

Primary cutaneous plasmacytosis in a child. Is this a new entity?

2002

Plasma cell proliferations represent a heterogeneous spectrum of disorders. A 7-year-old Caucasian female had suffered an asymptomatic eruption on the trunk for 4 years. Physical examination revealed a plaque with scattered red-brown papules and nodules. Chemical analysis revealed normal proteinaemia. Histological examination of biopsy specimens showed dense perivascular and periadnexal infiltrate, consisting largely of plasma cells, in the superficial and deep dermis. Immunohistochemical study showed that many cells of the infiltrate were CD20 positive. The plasma cells expressed kappa and lambda light chains. The girl's status (age; absence of hypergammaglobulinaemia, lymphadenopathy and …

Pathologymedicine.medical_specialtySkin NeoplasmsPlasma CellsHepatosplenomegalyDermatologyPlasma cellAsymptomaticRisk AssessmentSeverity of Illness IndexDermisBiopsymedicineHumansChildCD20medicine.diagnostic_testbiologybusiness.industryPlasmacytosisBiopsy Needlemedicine.diseaseImmunohistochemistryInfectious Diseasesmedicine.anatomical_structurebiology.proteinPlasmacytomaFemalemedicine.symptombusinessFollow-Up StudiesPlasmacytomaJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct

Progressive symmetric erythro-keratosis associated with oligodontia, severe caries, disturbed hair growth and ectopic nail: a new syndrome?

2008

A 7-year-old girl had well-demarcated erythematous plaques covered with white pityriasiform scales which were symmetrically distributed and involved the extensor surfaces of the extremities as well as the abdomen, buttocks and face. Histological examination showed marked hyperkeratosis with parakeratosis, and a thickened granular cell layer, mild acanthosis and slight lymphocytic infiltration surrounding the papillary blood vessels, compatible with a diagnosis of progressive symmetrical erythrokeratodermia. Remarkably, a keratotic excrescence similar to a normal nail plate involved the tip of the nose since the age of 6 months. Moreover, occipital hairlessness, oligodontia and severe caries…

HyperkeratosisAcanthosisDermatologyOligodontiaDental CariesProgressive symmetric erythrokeratodermiaDiagnosis DifferentialErythrokeratodermiaErythematous plaqueSettore MED/35 - Malattie Cutanee E VenereemedicineHumansAbnormalities MultipleParakeratosisChildAnodontiaHyperkeratosis Epidermolyticbusiness.industryProgressive symmetric erythro-keratosis new syndromeAnatomySyndromeNail platemedicine.diseaseNailsFemalemedicine.symptombusinessHairDermatology (Basel, Switzerland)
researchProduct

Simultaneous diagnosis of Kaposi's sarcoma, psoriasis, vitiligo and monoclonal gammopathy of undetermined significance in an immunocompetent patient

2013

medicine.medical_specialtyPathologybusiness.industryDermatologyGeneral MedicineVitiligomedicine.diseaseDermatologyPsoriasisMedicineSarcomabusinessKaposi's sarcomaMonoclonal gammopathy of undetermined significanceThe Journal of Dermatology
researchProduct

Psoriasis and cardiovascular risk: Assessment by cuore project risk score in Italian patients

2013

Background. Psoriasis is a common inflammatory and immune-mediated skin disease. There is growing controversy as to whether cardiovascular risk is elevated in psoriasis. A number of studies suggest a high prevalence of cardiovascular risk factors as well as cardiovascular diseases in psoriasis patients. Objective. The objective of this study was to estimate cardiovascular risk score in psoriasis patients and the relation between cardiovascular risk and psoriasis features. Cardiovascular risk was assessed by CUORE project risk score built within the longitudinal study of the Italian CUORE project and suited to populations with a low rate of coronary heart disease. Results. A case-control stu…

medicine.medical_specialtyLongitudinal studyFramingham Risk ScoreArticle Subjectbusiness.industryProject risk managementPsychological interventionDermatologyDiseaselcsh:RL1-803medicine.diseaseInternal medicinePsoriasisPsoriasis psoriasis and cardiovascular riskPhysical therapylcsh:DermatologyMedicineIn patientbusinessRisk assessmentResearch Article
researchProduct

Topical canrenoic acid. Quantification of the antiandrogenic activity in the hamster flank organ

1991

: The topical antiandrogenic activity of potassium canrenoate (CAK), compared with that of spironolactone (SP), was assayed in vivo in female golden Syrian hamsters whose flank organs were stimulated by subcutaneous administration of testosterone propionate. Sebaceous glands and hair were measured by a computerized image analyzer. Pigmented spots, sebaceous gland areas, and the diameter of hairs of the treated flank organs were smaller in the groups that received CAK (1·6 mg/day) and SP (0·4 mg/day). The authors' results showed that CAK may act as a topical antiandrogen on the hamster flank organ when applied in concentrations four times greater than the minimal active dosage of SP. Potassi…

Sebaceous glandTestosterone propionatemedicine.medical_specialtymedicine.drug_classAdministration TopicalHamsterDermatologySpironolactoneAntiandrogenchemistry.chemical_compoundSebaceous GlandsIn vivoInternal medicineCricetinaeMedicineAnimalsTestosteroneMesocricetusbusiness.industryAndrogen AntagonistsEndocrinologymedicine.anatomical_structurechemistryPotassium canrenoateSpironolactoneFemaleCanrenoic Acidbusinessmedicine.drug
researchProduct

Angiokeratoma: decision-making aid for the diagnosis of Fabry disease

2012

Isolated angiokeratomas are common benign cutaneous lesions, generally deemed unworthy of further investigation. In contrast, diffuse angiokeratomas should alert the physician to a possible diagnosis of Fabry disease, a rare X-linked lysosomal storage disorder, characterized by α-galactosidase deficiency. Glycosphingolipids accumulate in cells throughout the body resulting in progressive multi-organ failure. Difficulties are encountered when trying to interpret the significance of angiokeratomas because they may also occur in other lysosomal storage disorders and rarely in an isolated manner in Fabry disease. We present an algorithm for the classification of angiokeratomas which might prove…

Pathologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryVascular diseaseDermatologyDiseaseEnzyme replacement therapymedicine.diseaseFabry's diseaseFabry diseaseDermatologyAngiokeratomaSkin biopsyMedicineFamily historybusinessBritish Journal of Dermatology
researchProduct

Our experience with prurigo nodularis treated with dupilumab.

2020

medicine.medical_specialtyprurigo nodularibusiness.industryPruritusMEDLINEDermatologyDupilumabmedicine.diseaseAntibodies Monoclonal HumanizedDupilumabDermatologyInfectious DiseasesMedicineHumansPrurigobusinessNeurodermatitisPrurigo nodularisNeurodermatitisJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct

Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient

2008

Abstract CONTEXT: Lipase maturation factor 1 (LMF1) gene is a novel candidate gene in severe hypertriglyceridemia. Lmf1 is involved in the maturation of lipoprotein lipase (LPL) and hepatic lipase in endoplasmic reticulum. To date only one patient with severe hypertriglyceridemia and related disorders was found to be homozygous for a nonsense mutation in LMF1 gene (Y439X). OBJECTIVE: The objective of the study was to investigate LMF1 gene in hypertriglyceridemic patients in whom mutations in LPL, APOC2, and APOA5 genes had been excluded. RESULTS: The resequencing of LMF1 gene led to the discovery of a novel homozygous nonsense mutation in one patient with severe hypertriglyceridemia and rec…

Nonsynonymous substitutionMalecongenital hereditary and neonatal diseases and abnormalitiesPathologymedicine.medical_specialtyHeterozygoteNeurofibromatosis 1BiopsyDNA Mutational AnalysisMutation MissenseSoft Tissue NeoplasmsDermatologymassive soft tissue neurofibromas NeurofibromatosisBiologymedicine.disease_causeFrameshift mutationExonGenes Neurofibromatosis 1medicineSettore MED/35 - Malattie Cutanee E VenereeMissense mutationHumansNeurofibromatosisFrameshift MutationGeneSicilyGeneticsMutationHeterozygote advantageGeneral MedicineExonsMiddle Agedmedicine.diseasenervous system diseasesGene Expression Regulation NeoplasticButtocks
researchProduct

Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection

2022

Background and Objective Biologics for psoriasis, especially anti-tumor necrosis factor-alpha therapies, may reactivate hepatitis B virus (HBV) or hepatitis C virus (HCV) infections, as well in inactive carriers or patients with occult infection. However, some biologics, including anti-interleukin-17 therapies such as secukinumab, seem to be less likely to cause hepatitis reactivation. This study assessed the safety of secukinumab treatment in patients with psoriasis with HBV or HBC infection. Methods This was a retrospective cohort study of patients with moderate-to-severe psoriasis treated with secukinumab at seven Italian centers. Patients serologically positive for one or more of the fo…

Hepatitis B virusSecukinumab.HepacivirusAntibodies Monoclonal HumanizedAntiviral AgentsAntibodiesHepatitis B ChronicMonoclonalHumansPsoriasisPharmacology (medical)ViralChronicHumanizedRetrospective StudiesPsoriasiBiological ProductsHepatitis B Surface AntigensHepatitis ReactivationGeneral MedicineDNAAntibodies Monoclonal Humanized; Antiviral Agents; DNA Viral; Hepacivirus; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; RNA; Retrospective Studies; Virus Activation; Biological Products; Hepatitis B; Hepatitis B Chronic; Hepatitis C; Psoriasispsoriasis treatment secukinumab hepatitis B hepatitis CHepatitis BHepatitis CDNA ViralRNAVirus Activation
researchProduct

Targeting Phosphatases and Kinases: How to Checkmate Cancer

2021

Metastatic disease represents the major cause of death in oncologic patients worldwide. Accumulating evidence have highlighted the relevance of a small population of cancer cells, named cancer stem cells (CSCs), in the resistance to therapies, as well as cancer recurrence and metastasis. Standard anti-cancer treatments are not always conclusively curative, posing an urgent need to discover new targets for an effective therapy. Kinases and phosphatases are implicated in many cellular processes, such as proliferation, differentiation and oncogenic transformation. These proteins are crucial regulators of intracellular signaling pathways mediating multiple cellular activities. Therefore, altera…

cancer stem cellkinaseQH301-705.5PopulationPhosphataseDiseaseReviewBiologyMetastasisphosphatasecancer stem cell kinase phosphatase phosphatase and kinase inhibitors targeted therapiesCell and Developmental BiologyCancer stem cellmedicineBiology (General)educationphosphatase and kinase inhibitorseducation.field_of_studyKinaseCancerCell Biologymedicine.diseasetargeted therapiesCancer cellCancer researchDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct

Multiple nevoid spiradenomas.

1994

This report delineates a new clinical presentation of multiple benign spiradenoma (BS), a diffuse linear nevoid pattern. A 16-year-old girl, in otherwise good health, had many papulonodular lesions, varying in color from blue-gray to bright red, disposed linearly on the right half of her body, involving the periorbital region, cheek, lateral side of the neck, trunk, linea alba, right thigh, and leg. Only a few nodules were slightly painful. Lesions were reported to be present at birth; no family members had similar lesions, either in solitary or multiple form. Excisional biopsies of three lesions from the neck, abdomen, and leg, respectively, were performed; histologically, all three sample…

AdolescentMultiple formsbusiness.industryAdenoma Sweat GlandDermatologyGeneral MedicineAnatomyCheekmedicine.diseaseTrunkPathology and Forensic MedicineNeoplasms Multiple PrimarySweat Gland Neoplasmsmedicine.anatomical_structuremedicineLinea alba (abdomen)AbdomenHumansFemalePresentation (obstetrics)SpiradenomabusinessRight ThighThe American Journal of dermatopathology
researchProduct

Preliminary communication: imiquimod in mixed capillary/lymphatic malformation.

2008

:  The present authors reported a 14-year-old white boy who visited the present authors’ dermatology department in January 2004. Physical examination revealed multiple translucent and hemorrhagic vesicles and skin-colored nodules on the chin. The lesion had grown slowly in size over the previous 7 years. The objective of this study is to estimate the exact mechanism of action of topical imiquimod on mixed capillary/lymphatic malformation. After 4 weeks of therapy the lesions were less protuberant. At the follow-up examination after a further 2 months of therapy, there was partial clinical regression of the capillary component with a return to normal skin color. One month after termination o…

Malemedicine.medical_specialtyChinAdolescentPhysical examinationImiquimodDermatologyLesionAdjuvants ImmunologicmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansLymphatic VesselsImiquimodLymphatic Abnormalitiesmedicine.diagnostic_testbusiness.industryDermatology departmentGeneral MedicineDermatologyChinSurgeryCapillariesLymphatic systemmedicine.anatomical_structureimiquimod mixed capillary/lymphatic malformationAminoquinolinesmedicine.symptomTopical imiquimodFacial NeoplasmsNormal skinbusinessHemangiomamedicine.drugDermatologic therapy
researchProduct

Matrix metalloproteinases 2 and 9 in lentigo maligna melanoma

2009

Settore MED/35 - Malattie Cutanee E VenereeMatrix metalloproteinases lentigo maligna melanoma
researchProduct

Possible role of polycyclic aromatic hydrocarbons in the onset of melanoma: preliminary data.

2019

Air PollutantsSkin Neoplasmsbusiness.industryMelanomaMEDLINEDermatologypolycyclic aromatic hydrocarbons melanomamedicine.diseaseBioinformaticsInfectious DiseasesText miningRisk FactorsSettore MED/35 - Malattie Cutanee E VenereeMedicineHumansPolycyclic Aromatic HydrocarbonsbusinessMelanomaPreliminary Data
researchProduct

Sweat Gland Biopsy: A Possible Early Diagnostic Tool in the Anderson-Fabry Disease

2016

Anderson-Fabry disease is a rare X-linked lysosomal storage disorder caused by deficient or absent activity of the enzyme alfa-galactosidase A. This defect enzyme leads to accumulation of glycolipids, primarily globotriaosylceramide (Gb3), in the vascular endothelium of several organs, including the skin, kidneys, nervous system, and heart. The characteristic early clinical features of Fabry disease include acroparaesthesia, angiokeratoma, heat intolerance, hypohidrosis, cornea verticillata and gastrointestinal symptoms. Later complications occur with the disease progression and include progressive renal failure, hypertrofic cardiomyopathy, cerebrovascular disease and reduced life expectanc…

dermatologyPathologymedicine.medical_specialtyAnderson-Fabry Diseasemedicine.anatomical_structuremedicine.diagnostic_testbusiness.industrySweat glandBiopsyMedicinebusiness
researchProduct

A Rare Presentation of Mycosis Fungoides Mimicking Psoriasis Vulgaris

2009

Mycosis fungoides (MF) is an uncommon primary cutaneous lymphoma with a wide spectrum of clinicopathological manifestations. Diagnosis can be difficult in its early stages given the considerable overlap with more common benign dermatoses. We report an unusual case of MF in a 52-year-old male presenting with psoriasiform plaques on the palms and the soles who rapidly developed additional lesions on the scalp, limps and trunk. Punch biopsy of the face was obtained for routine histology and immunohistochemical stains. Chest X-ray, total body computed tomography scanning and excisional biopsy of the inguinal lymph node were performed. Review of the face biopsy revealed a diffuse dermal infiltra…

Mycosis fungoidesMycosis fungoidesPathologymedicine.medical_specialtyAtypical LymphocyteMycosis fungoides Cutaneous lymphoma Psoriasismedicine.diagnostic_testbusiness.industryHistologyDermatologylcsh:RL1-803medicine.diseaseDermatologyCutaneous lymphomamedicine.anatomical_structureImmunophenotypingCutaneous lymphomaPsoriasisScalpBiopsymedicinelcsh:DermatologyCase Reports in DematologyPsoriasisbusinessCase Reports in Dermatology
researchProduct

Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant

2020

Abstract Despite intense research and clinical efforts, patients affected by advanced colorectal cancer (CRC) have still a poor prognosis. The discovery of colorectal (CR) cancer stem cell (CSC) as the cell compartment responsible for tumor initiation and propagation may provide new opportunities for the development of new therapeutic strategies. Given the reduced sensitivity of CR-CSCs to chemotherapy and the ability of bone morphogenetic proteins (BMP) to promote colonic stem cell differentiation, we aimed to investigate whether an enhanced variant of BMP7 (BMP7v) could sensitize to chemotherapy-resistant CRC cells and tumors. Thirty-five primary human cultures enriched in CR-CSCs, includ…

0301 basic medicineCancer ResearchColorectal cancerBone Morphogenetic Protein 7Cellular differentiationCellAntineoplastic AgentsTumor initiationBiologyArticleMice03 medical and health sciences0302 clinical medicineSettore MED/04 - PATOLOGIA GENERALECancer stem cellCell Line TumorGeneticsmedicineAnimalsHumansbmp7Molecular BiologyPI3K/AKT/mTOR pathwayPhosphoinositide-3 Kinase InhibitorsCancer stem cellsMesenchymal stem cellWnt signaling pathwayCell Differentiationmedicine.diseasecolorectal cancer bmp7Colorectal cancerXenograft Model Antitumor Assays030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisMutationNeoplastic Stem CellsCancer researchColorectal NeoplasmsOncogene
researchProduct

Vascular patterns in cutaneous leishmaniasis: A videodermatoscopic study

2015

AdultMalemedicine.medical_specialtyAdolescentBlood VesselVideo RecordingLeishmaniasis CutaneousDermoscopyDermatologySkin Diseases VascularYoung AdultCutaneous leishmaniasislcsh:DermatologyHumansMedicineLeishmania infantumChildAgedVideo recordingbiologybusiness.industryLeishmaniasis CutaneouLeishmaniasisDNA ProtozoanMiddle Agedlcsh:RL1-803biology.organism_classificationmedicine.diseaseDermatologyInfectious DiseasesChild PreschoolBlood VesselsFemaleVascular pathologyLeishmania infantumbusinessHuman2708Indian Journal of Dermatology, Venereology, and Leprology
researchProduct

Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma

2010

Matrix metalloproteinases (MMPs) are associated with Kaposi's sarcoma (KS) tumorigenesis and may contribute to the mechanism of KS invasive growth. To date, only a few MMPs have been studied in KS lesions, and exactly which MMPs are involved in KS development and progression remains unanswered. However, MMPs 2 and 9 have been associated with different phases of angiogenesis, but their role in the proteolytic modification of the extracellular matrix has not been investigated. The results of this study confirm that MMPs, specifically MMP-2 and MMP-9, can contribute to angiogenesis by disrupting the vessel basement membrane and other extracellular matrix barriers, and enabling endothelial cell…

Skin NeoplasmsAngiogenesisDermatologyMatrix metalloproteinasemedicine.disease_causeBasement MembraneExtracellular matrixCell Movementmatrix metalloproteinase-9Settore MED/35 - Malattie Cutanee E VenereemedicineHumansSarcoma KaposiKaposi's sarcomaBasement membraneNeovascularization Pathologicbusiness.industryGeneral Medicinemedicine.diseaseVirologyExtracellular Matrixmedicine.anatomical_structureMatrix Metalloproteinase 9Invasive growthsarcoma of KaposiCancer researchMatrix Metalloproteinase 2SarcomaCarcinogenesisbusinessmatrix metalloproteinase- 2Dermatologic Therapy
researchProduct

Assessment of etanercept efficacy in the treatment of psoriatic arthritis: ultrasonography of Achilles tendon

2015

medicine.medical_specialtyMEDLINEArthritisDermatologyAchilles TendonEtanerceptEtanercept030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritis0302 clinical medicinemedicineHumansUltrasonography030203 arthritis & rheumatologyAchilles tendonbusiness.industryArthritis Psoriaticmedicine.diseaseDermatologymedicine.anatomical_structureInfectious DiseasesUltrasonographybusinessmedicine.drugHuman2708
researchProduct

Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection

2022

Background Some biologics for psoriasis, especially anti-tumor necrosis factor (TNF)-alpha therapies, may re-activate latent tuberculosis (TBC) infection with consequent morbidity and mortality. However, there is a low reported incidence of conversion to positive TBC status among patients with psoriasis treated with second-generation biologic therapies, particularly anti-interleukin (IL)-17 therapies such as secukinumab. Objectives To evaluate the safety profile of secukinumab in psoriasis patients with latent TBC infection. Methods Real-life data were collected by retrospective chart review on patients with moderate-to-severe psoriasis who showed positivity for TBC screening at baseline an…

reactivationBiologicpsoriasis.latent tuberculosis infectionsecukinumabchemoprophylaxisDermatologyBiologicsBiologics; chemoprophylaxis; latent tuberculosis infection; psoriasis; reactivation; secukinumab.Antibodies Monoclonal HumanizedSeverity of Illness IndexTreatment OutcomeLatent TuberculosisIsoniazidHumansPsoriasisTuberculosisRifampinchemoprophylaxiRetrospective Studiespsoriasi
researchProduct

Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells

2022

Despite advances in the curative approach, the survival rate of advanced colorectal cancer (CRC) patients is still poor, which is likely due to the emergence of cancer cell clones resistant to the available therapeutic options. We have already shown that CD44v6-positive CRC stem cells (CR-CSCs) are refractory toward standard anti-tumor therapeutic agents due to the activation of the PI3K pathway together with high HER2 expression levels. Tumor microenvironmental cytokines confer resistance to CR-CSCs against HER2/PI3K targeting by enhancing activation of the MAPK pathway. Here, we show that the CSC compartment, spared by BRAF inhibitor-based targeted therapy, is associated with increased ex…

cancer stem cellsCancer ResearchOncologySettore MED/04 - PATOLOGIA GENERALECancer stem cellCombination therapies.anti-tumor drug resistanceanti-tumor drug resistance; colorectal cancer; combination therapies; cancer stem cellsNeoplasms. Tumors. Oncology. Including cancer and carcinogenscolorectal cancerSettore MED/46 - Scienze Tecniche Di Medicina Di Laboratoriocombination therapiesRC254-282Cancers
researchProduct

Reflectance mode confocal microscopy and digital image analysis in naevus of Hori and pathogenetic evaluation

2012

Pathologymedicine.medical_specialtyOpticsbusiness.industryConfocal microscopylawDigital image analysisMode (statistics)MedicineDermatologybusinessReflectivitylaw.inventionBritish Journal of Dermatology
researchProduct

Unusual clinical variants of cutaneous leishmaniasis in Sicily

2009

Background  The term “leishmaniasis” defines a group of vector-borne diseases caused by species of the genus Leishmania and characterized by a spectrum of clinical manifestations. Parasite properties (infectivity, pathogenicity, virulence), host factors, and host responses regulate heterogeneous disease expression. Sicily is one of the major islands of the Mediterranean Basin and is considered to be a hypo-endemic area for cutaneous leishmaniasis. Leishmania infantum is the most common species on the island. Methods  Fifty patients (both sexes and different ages) with lesions clinically suggestive of cutaneous leishmaniasis were recorded over a 1-year period. The diagnosis was based on posi…

AdultMaleAdolescentErysipeloidLeishmaniasis CutaneousVirulenceDermatologylaw.inventioncutaneous leishmaniasisYoung AdultCutaneous leishmaniasislawSettore MED/35 - Malattie Cutanee E VenereeAnimalsHumansMedicineLeishmania infantumChildSicilyPolymerase chain reactionAgedSkinAged 80 and overInfectivitybiologybusiness.industryInfantLeishmaniasisMiddle Agedmedicine.diseasebiology.organism_classificationLeishmaniaChild PreschoolImmunologyFemaleLeishmania infantumbusinessInternational Journal of Dermatology
researchProduct

Recapitulating thyroid cancer histotypes through engineering embryonic stem cells

2023

AbstractThyroid carcinoma (TC) is the most common malignancy of endocrine organs. The cell subpopulation in the lineage hierarchy that serves as cell of origin for the different TC histotypes is unknown. Human embryonic stem cells (hESCs) with appropriate in vitro stimulation undergo sequential differentiation into thyroid progenitor cells (TPCs-day 22), which maturate into thyrocytes (day 30). Here, we create follicular cell-derived TCs of all the different histotypes based on specific genomic alterations delivered by CRISPR-Cas9 in hESC-derived TPCs. Specifically, TPCs harboring BRAFV600E or NRASQ61R mutations generate papillary or follicular TC, respectively, whereas addition of TP53R248…

MultidisciplinaryGeneral Physics and AstronomyGeneral ChemistryGeneral Biochemistry Genetics and Molecular BiologyThyroid cancer thyroid progenitor cells genetic mutation model CD44 TIMP1 KISS1 KISS1R.
researchProduct

Histopathological progression of hidradenitis suppurativa/acne inversa

2021

It is generally acknowledged that the first morphological change of hidradenitis suppurativa/acne inversa (HS/AI) consists of infundibular plugging of the folliculosebaceous apocrine apparatus, which is followed by acute and chronic inflammation, cysts with sinus formation, and fibrosis. Alternatively, it has been hypothesized that HS/AI is primarily a neutrophilic autoinflammatory disease and that the follicular plugging typical of this disease is secondary to inflammation.To review the sequence of the changes that mark the disease development, we have performed a histopathologic study on the surgical material from a series of axillary and inguinal/perineal cases.The histologic material fr…

Early lesionPathologymedicine.medical_specialty030209 endocrinology & metabolism030204 cardiovascular system & hematologyInner root sheathPathogenesis03 medical and health sciences0302 clinical medicineFibrosismedicineHumansHidradenitis suppurativaPathologicalAcneSkinInflammationbusiness.industryApocrineDevelopmental disturbanceGeneral Medicinemedicine.diseaseImmunohistochemistryHidradenitis SuppurativaMutationAutoinflammationImmunohistochemistryUninvolved skinbusinessHair FollicleWiener Medizinische Wochenschrift
researchProduct

Gender differences in adverse drug reactions in dermatological patients in west Sicily: an epidemiological study

2013

Purpose: The purpose of this study was to show that gender also plays an important role in pharmacokinetics, pharmacodynamics, and drug toxicity. It is only fair to take into account the so-called “gender-based medicine.” Methods: We again selected admission for cutaneous adverse drug reaction (CADRs), from January 2012 to July 2012, in order to detect and verify, in an analytical way, the substantial gender differences in adverse drug reactions in term incidence, clinical manifestations, severity and drugs involved. Results:In the period January–July 2012, at the Department of Dermatology and Sexually Transmitted Disease of A.O.U.P. “Paolo Giaccone” Palermo, 384 patients were admitted, of …

AdultMaleSexually transmitted diseasemedicine.medical_specialtyDermatologyPharmacologySex FactorsPharmacokineticsInternal medicineEpidemiologyPharmacovigilancemedicineSettore MED/35 - Malattie Cutanee E VenereeHumansSicilyRetrospective Studiesbusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyadverse drug reactions gender-based medicine pharmacovigilanceMiddle Agedmedicine.diseasePharmacodynamicsFemaleDrug EruptionsbusinessAdverse drug reaction
researchProduct

Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

2022

AbstractBreast cancer (BC) is the second cause of cancer-related deceases in the worldwide female population. Despite the successful treatment advances, 25% of BC develops resistance to current therapeutic regimens, thereby remaining a major hurdle for patient management. Current therapies, targeting the molecular events underpinning the adaptive resistance, still require effort to improve BC treatment. Using BC sphere cells (BCSphCs) as a model, here we showed that BC stem-like cells express high levels of Myc, which requires the presence of the multifunctional DNA/RNA binding protein Sam68 for the DNA-damage repair. Analysis of a cohort of BC patients displayed that Sam68 is an independen…

cancer stem cellCancer Researchtherapy resistanceDNA RepairSettore MED/50 - Scienze Tecniche Mediche ApplicateCell Cycle ProteinsBreast NeoplasmsTriple Negative Breast NeoplasmsMycCell LineBreast cancerSettore MED/04 - PATOLOGIA GENERALECell Line TumorGeneticsHumansMolecular BiologyAdaptor Proteins Signal TransducingTumorSignal TransducingRNA-Binding ProteinsAdaptor ProteinsDNA-Binding ProteinsSam68Neoplastic Stem CellsFemaleRad51 RecombinaseSettore MED/46 - Scienze Tecniche Di Medicina Di Laboratorio
researchProduct

Prolidase deficiency in two dermatological patients in western Sicily

2020

Prolidase deficiency is a rare disorder inherited through an autosomal recessive gene. The hallmark of the disorder are iminodipeptiduria, chronic skin ulcers, recurring infections, mental retardation and characteristic facial appearance, although prolidase deficiency can occur with no clinical manifestation. The primary biological function of the enzyme involves the metabolism of collagen degradation products and the recycling of proline for collagen resynthesis. We describe two patients with prolidase deficiency and review the different clinical manifestations suggesting the pathogenetic mechanism through few hypotheses.

Adult030203 arthritis & rheumatologyProlidase deficiencyCollagen degradationbusiness.industryDermatologyClinical manifestationmedicine.disease030207 dermatology & venereal diseases03 medical and health sciencesFacial appearanceChronic skin ulcers0302 clinical medicineImmunologymedicineHumansFemaleProlidase deficiency ulcersProlidase DeficiencyIminodipeptiduriabusinessSicilyGiornale Italiano di Dermatologia e Venereologia
researchProduct

Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients.

2019

Background: Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease characterized by a significant impairment of patients’ quality of life (QoL). It has been recently found that clinical severity of HS does not correlate well with QoL. Therefore, it is important to enhance the evaluation of severity considering the disease burden on QoL. Recently, a new graphical tool able to better describe HS burden, the so-called HIDRAdisk, has been introduced. Objective: To investigate the utility of HIDRAdisk in clinical practice before and after treatment and to analyse whether specific factors such as age and gender may influence the outcomes in patients with moderate-to-severe…

AdultMalemedicine.medical_specialtyVisual Analog ScaleDermatology.Severity of Illness IndexAge and gender030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsDisease severityQuality of lifeHidradenitis suppurativa quality of lifeCost of IllnessInternal medicinemedicineAdalimumabHumansIn patientHidradenitis suppurativa030212 general & internal medicineDisease burdenRetrospective Studiesbusiness.industryAge FactorsRetrospective cohort studyMiddle Agedmedicine.diseaseHidradenitis SuppurativaInfectious DiseasesTreatment OutcomeQuality of LifeFemalebusinessSettore MED/35 - MALATTIE CUTANEE E VENEREEHIDRAdisk outcomesmedicine.drughidradiskJournal of the European Academy of Dermatology and Venereology : JEADVReferences
researchProduct

Primary malignant melanoma of the oral cavity: case report.

2002

An 80-year-old-female patient had a pigmented lesion on: the hard palate, the soft palate, the alveolar mucosa and the vestibolar mucosa of the maxillary gingiva. Pigmented macules and patchs had been persistent and asymptomatic for many years (Fig. 1). The lesion exhibited irregularities of pigmentation, border and surface contour. About 1 year later the patient had noticed an extension of the pigmented macules and plaques; there was also the appearance of nodules of the maxillary gingiva accompanied by swelling. Loosening of teeth as a result of extensive destruction of bone was further noted (Fig. 2). Figure 1. Pigmented macules and patchs with irregularities of pigmentation, border and …

Pathologymedicine.medical_specialtyDermatologyS100 proteinLesionDiagnosis DifferentialDermisAntigens NeoplasmSubmucosamedicineHumansMelanomaAlveolar mucosaAgedAged 80 and overbusiness.industryS100 ProteinsAnatomyImmunohistochemistryNeoplasm Proteinsmedicine.anatomical_structureFemaleMouth NeoplasmsHard palateEpidermismedicine.symptombusinessEpithelioid cellMelanoma-Specific AntigensInternational journal of dermatology
researchProduct

Tuberculoid leprosy and Type 1 lepra reaction.

2008

Summary A patient is described with tuberculoid leprosy and Type 1 (lepra) reaction from Sicily a non-endemic region, who lived previously in Manila from 2000 to 2005. The skin lesions became acutely inflamed and edematous. The plaques were painless to touch or pinprick, and there was swelling of the nerves in the fibro-osseous tunnels under the surface of the skin, including both the ulnar nerve at the elbow, and the posterior tibial nerve (medial malleolus). During the course of electro-neurographic studies, conduction velocity in the motory nerves indicated a slowing-down. The diagnosis of leprosy was confirmed by residence in an endemic area for about 5 years, by simultaneous skin lesio…

AdultMalePathologymedicine.medical_specialtyPosterior tibial nerveBiopsyPhilippinesElbowNeural ConductionTuberculoid leprosyLeprostatic AgentsClofazimineNerve conduction velocityDiagnosis DifferentialmedicineHumansUlnar nerveSicilyTravelmedicine.diagnostic_testbusiness.industryPublic Health Environmental and Occupational HealthTuberculoid leprosy Type 1 lepra reaction.medicine.diseaseLeprosy TuberculoidInfectious Diseasesmedicine.anatomical_structureSkin biopsyLeprosyDifferential diagnosisRifampinbusinessDapsone
researchProduct

Timing of quality of life improvements in psoriatic patients treated with different systemic therapies

2019

Psoriasis impacts the quality of life (QoL) by disrupting overall health and social life. Thus, the use of a QoL evaluation item is crucial in assessing a therapeutic regimen. Also, faster improvements in QoL lead to better patient compliance, but very few studies compare psoriasis traditional and biologic therapies timing. To evaluate how much different systemic therapies improve disease severity and QoL, a retrospective analysis was performed on 56 patients. Subjects were administered different drugs and their vital statistics, psoriasis area severity index (PASI) and PSOdisk were collected at baseline and after 30 days. We found a moderate correlation between PASI and PSOdisk score with …

AdultMalemedicine.medical_specialtyTime FactorsAdolescentAnti-Inflammatory AgentsDermatologySeverity of Illness IndexSocial lifeYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDisease severityQuality of lifeSurveys and QuestionnairesPsoriasisInternal medicinesystemic therapiesUstekinumabmedicineHumansPsoriasisPatient complianceAgedRetrospective StudiesSkinpsoriasiAged 80 and overTherapeutic regimenbusiness.industryBiologic therapiesAdalimumabGeneral MedicineMiddle Agedmedicine.diseasehumanitiesBiological TherapyTreatment Outcomequality of life030220 oncology & carcinogenesisCyclosporineFemaleUstekinumabDermatologic AgentsbusinessFollow-Up Studiesmedicine.drug
researchProduct

Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease

2022

<b><i>Background:</i></b> Hidradenitis suppurativa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicle that usually occurs after puberty with painful, deep-seated, inflamed nodules and sinus tracts in the apocrine gland-bearing areas of the body, most commonly the axillae and inguinal and anogenital regions, with a relevant impact on patients’ quality of life (QoL). <b><i>Objective:</i></b> To evaluate how the burden of HS disease impacts on patient well-being and working activities in a large Italian population over a period of 9 months. <b><i>Methods:</i></b> A multicenter, prosp…

Burden of diseaseAdultMalemedicine.medical_specialtyHIDRAdiskDermatologyDiseaseSeverity of Illness IndexBurden of disease; HIDRAdisk; Hidradenitis suppurativa; Quality of lifeCohort StudiesYoung AdultQuality of lifeCost of IllnessInternal medicinemedicineHumansHidradenitis suppurativaProspective StudiesStage (cooking)Disease burdenQuality of life.Prostaglandins Abusiness.industryBurden of diseaseDermatology Life Quality IndexMiddle Agedmedicine.diseaseCost of IllneProspective StudieHidradenitis suppurativaItalyQuality of LifeFemaleCohort StudiebusinessCohort studyHuman
researchProduct

Cutaneous complications of Anderson-Fabry disease.

2013

Anderson-Fabry disease is an X-linked lysosomal storage disorder caused by a defect in the -galactosidase A gene, which leads to the deficiency of the hydrolytic enzyme -galactosidase A. The consequent inability to catabolize glycosphingolipids causes progressive accumulation of globotriaosylceramide in the vascular endothelium throughout the body. Fatalities in the classical phenotype may usually occur as a consequence of cerebral, cardiac or renal disease. Dermatological manifestations are a relevant feature of Fabry disease and include angiokeratomas, telangiectasiae, lymphedema, anhidrosis or hypohidrosis and pseudo-acromegalic facial appearance. The actual causal treatment for Fabry …

MalePathologymedicine.medical_specialtySkin NeoplasmsGlobotriaosylceramideDiseaseDiagnosis Differentialchemistry.chemical_compoundDrug DiscoverymedicineHumansAge FactorEnzyme Replacement TherapySkin NeoplasmAnhidrosisSkinPharmacologySex CharacteristicsVascular diseasebusiness.industryAge FactorsEnzyme replacement therapySex Characteristicmedicine.diseaseFabry diseaseAngiokeratomaLymphedemachemistryalpha-GalactosidaseFabry DiseaseFemalemedicine.symptombusinessHumanAngiokeratomaCurrent pharmaceutical design
researchProduct

Myiasis with Dermatobia hominis in a Sicilian traveller returning from Peru

2007

Summary We report a case of a bot fly infestation of the scalp. A 45-year-old man after returning to Sicily noted a small white “worm” erupting from the upper lesion. Physical examination revealed a superficial furuncular lesion with central pores with sero-sanguineous discharge. The foreign body identified was diagnosed as the larva of the human bot fly, Dermatobia hominis.

Malemedicine.medical_specialtyVeterinary medicinemedicine.disease_causeDiagnosis DifferentialLesionMyiasisPeruparasitic diseasesInfestationmedicineAnimalsHumansSicilyTravelScalpbiologybusiness.industryDipterafungiPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseasebiology.organism_classificationDermatologylanguage.human_languageDermatobia hominisInfectious DiseasesLarvalanguagemedicine.symptomForeign bodyMyiasisbusinessSicilianTravel Medicine and Infectious Disease
researchProduct

Real-life practice: rapid improvement in itch symptomatology in patients with atopic dermatitis treated with dupilumab

2019

Sir,Atopic dermatitis is a chronic relapsing inflammatory skin disorder that affects up to 20% of children and 2–5% of the adult population (1). The disease is characterized by erythematous, xeroti...

030203 arthritis & rheumatologymedicine.medical_specialtybusiness.industryAdult populationMEDLINEDermatologyAtopic dermatitisDiseasemedicine.diseaseDupilumabDermatologybody regions030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineMedicineIn patientbusinessatopic dermatitis itchJournal of Dermatological Treatment
researchProduct

Avian mite dermatitis: an Italian case indicating the establishment and spread of Ornithonyssus bursa (Acari: Gamasida: Macronyssidae) (Berlese, 1888…

2015

Background Avian mite dermatitis is a skin disease caused in mammals by the incidental bites of blood-sucking mites which customarily parasitize wild and domestic birds. It manifests in the form of pruritic, erythematous, or urticarial papules, with a central sting mark, in skin regions normally covered by clothing. The species mainly implicated in human bite cases are Dermanyssus gallinae, Ornithonyssus sylviarum and, less frequently, Ornithonyssus bursa. The latter is mainly a tropical and subtropical mite and its – presumably transitory – presence has been recorded only once in Europe, in migratory birds. Case report We report a case of avian mite dermatitis in a 70-year-old man, an owne…

MaleVeterinary medicineMite InfestationsDermanyssus gallinaeDermatitisDermatologymedicine.disease_causeparasitic diseasesInfestationMitemedicineSettore MED/35 - Malattie Cutanee E VenereeAnimalsHumansAcariSicilyPoultry DiseasesAgedMitesintegumentary systembiologyOrnithonyssus bursa human infestation Alien speciesEuropebiology.organism_classificationArthropod mouthpartsStingMacronyssidaeOrnithonyssus bursaIntroduced SpeciesChickensInternational journal of dermatology
researchProduct

Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.

2011

Introduction: Pemphigus is an autoimmune blistering disease of the skin and mucous membranes characterized by the development of autoantibodies against the desmosomal proteins, desmoglein-1 and -3. Before the advent of corticosteroids, therapy was almost fatal. The introduction of high-dose corticosteroid therapy has reduced mortality rates to similar to 10%, but long-term use of steroids can lead to side effects, many of which are severe and associated with significant morbidity. Thus, the major goal of pemphigus therapy has been to reduce the patient's cumulative exposure to systemic corticosteroids. Over the last 2 decades, a range of corticosteroid-sparing immunosuppressive agents have …

medicine.medical_specialtyToxicologyMycophenolateMycophenolic acidPharmacokineticsAdrenal Cortex HormonesmedicineInitial treatmentimmunosuppressant inosine monophosphate dehydrogenase mycophenolate mofetil mycophenolic acid pemphigus pharmacokinetic treatmentHumansPharmacologyintegumentary systembusiness.industryMortality rateAutoantibodyGeneral MedicineMycophenolic Acidmedicine.diseaseDermatologyPemphigusImmunologybusinessImmunosuppressive AgentsPemphigusmedicine.drugBlistering diseaseExpert opinion on drug metabolismtoxicology
researchProduct

The behaviour of Bcl-2, Bax and Bcl-x in Darier's disease

2002

SummaryBackground Darier's disease (DD) is a rare autosomal dominant disorder of keratinization caused by a mutation of the ATP2A2 gene. There is little information on the behaviour of Bcl-2, Bax and Bcl-x in DD. Objectives To investigate the dynamic control and the behaviour of Bax, Bcl-2 and Bcl-x in DD. We asked whether members of the Bcl-2 family might manifest their effects through modulation of intracellular calcium signalling or whether the gene that encodes the sarco/endoplasmic reticulum Ca2+ ATPase isoform 2 (SERCA2) modulates the Bcl-2 family in the regulation of apoptosis in DD. Methods Immunohistochemical methods were used. Results There was no immunoreactivity for Bcl-2 and Bc…

AdultKeratinocytesMaleGene isoformbcl-X ProteinApoptosisDermatologyBiologymedicine.disease_causeProto-Oncogene ProteinsATP2A2KeratinDarier's diseasemedicineHumansbcl-2-Associated X Proteinchemistry.chemical_classificationMutationEpidermis (botany)Endoplasmic reticulummedicine.diseaseProto-Oncogene Proteins c-bcl-2chemistryApoptosisImmunologyCancer researchFemaleEpidermisDarier DiseaseBritish Journal of Dermatology
researchProduct

Naevus Comedonicus Immunohistochemical Features in Two Cases

2003

Sir, Naevus comedonicus was first described by Kofmann in 1895 (1). It was arranged in groups or linear patterns along Blaschko’s line and located on the face, neck, upper arms, chest and abdomen. It has been well documented that naevus comedonicus occurs as a single entity but occasionally in association with other disorders. The objective of this study was to analyse the clinical and immunohistochemical features of two patients with extensive naevus comedonicus arranged in groups and linear patterns without non-cutaneous abnormalities.

Upper Armsgenetic structuresSingle entitybusiness.industryMedicineImmunohistochemistryDermatologyGeneral MedicineAnatomyskin and connective tissue diseasesbusinesseye diseasesNaevus comedonicusActa Dermato-Venereologica
researchProduct

A pigmented papule acting like a playful ghost: dermoscopy of three targetoid hemosiderotic hemangiomas

2018

Targetoid hemosiderotic hemangioma represents an uncommon, distinctive, benign lympho-vascular lesion, with a variable clinical appearance, typically occurs in the lower limbs and trunk. Most patients are in their 20's or 30's. We describe three dermoscopic cases followed by the review of the literature. Dermoscopic images have been collected and have been evaluated for the presence of dermoscopic features. Concerning the review, we researched on pubmed and records were reviewed noting patient age of onset, sex, location, overall size, dermoscopic appearance. The harmonic mean age of patients was 31 years; the female-to-male ratio was 1:1, and the most common locations were lower extremitie…

Adultmedicine.medical_specialtySkin NeoplasmsTargetoid hemosiderotic hemangiomaDermoscopyDermatologyLesionDiagnosis Differential030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineDermismedicineHumanshemosiderotic hemangiomasbusiness.industryPapillary dermisEndothelial CellsPapuleClinical appearancemedicine.diseaseTrunkDermatologymedicine.anatomical_structureHomogeneous030220 oncology & carcinogenesisFemalemedicine.symptombusinessHemangioma
researchProduct

Neurofibromatosis of the nipple-areolar area: a case series

2010

Abstract Introduction Neurofibromatosis type 1 is an autosomal dominant disorder that occurs across all ethnic groups and affects approximately one in 4000 individuals. One of the most noticeable characteristics of the disease is the development of neurofibromas. Case presentation A total of 258 patients (131 women, 127 men) with neurofibromatosis type 1 were evaluated between 1994 and 2004 in our hospital's dermatology department. Nine patients (3.45%, 95% confidence limits 1.22 to 5.68) had neurofibromas of the breast. One of these nine patients presented with an extensive congenital plexiform neurofibroma in the outer quadrants of her right breast, extending to the nipple-areolar complex…

Medicine(all)medicine.medical_specialtyPathologybusiness.industryCase reportlcsh:Rmedicinelcsh:MedicineGeneral MedicineNeurofibromatosismedicine.diseasebusinessDermatologyJournal of Medical Case Reports
researchProduct

Erythroderma related to the administration of 99mTc-sestamibi: The first report

2009

MaleTechnetium Tc 99m Sestamibimedicine.medical_specialtybusiness.industryMEDLINEErythroderma99mTc Sestamibimedicine.diseaseInternal medicineSettore MED/35 - Malattie Cutanee E VenereemedicineHumansRadiology Nuclear Medicine and imagingDrug EruptionsRadiopharmaceuticalsCardiology and Cardiovascular MedicinebusinessAdministration (government)Dermatitis ExfoliativeAgedRadiopharmaceuticals Technetium 99m sestamibi erythroderma.Journal of Nuclear Cardiology
researchProduct

A novel mutation of the extracellular matrix protein 1 gene (ECM1) in a patient with lipoid proteinosis (Urbach-Wiethe disease) from Sicily

2005

Summary Background  Lipoid proteinosis (LP), also known as Urbach–Wiethe disease, is a rare autosomal recessive disorder characterized by a hoarse voice, warty skin infiltration and scarring. Mutations within the extracellular matrix protein 1 (ECM1) gene cause LP. Objectives  We report the molecular analysis of the ECM1 gene in a Sicilian patient with LP in order to extend the mutation spectrum of this genodermatosis. Methods  We studied a 32-year-old female born from consanguineous parents who was diagnosed at the age of 11 years as having LP. She has a clinical phenotype corresponding to Urbach–Wiethe disease characterized by papules/nodules, indurated plaques and sometimes ulcerated les…

AdultPathologymedicine.medical_specialtySettore MED/09 - Medicina InternaBiopsyMolecular Sequence DataNonsense mutationDermatologyBiologyUrbach–Wiethe diseasemedicine.disease_causePolymerase Chain ReactionFrameshift mutationExtracellular matrix protein 1ExonmedicineHumanseducationSicilyGeneExtracellular Matrix Proteinseducation.field_of_studyMutationBase SequenceGenodermatosisSkin Diseases Geneticmedicine.diseasePedigreeECM1 gene lipoid proteinosis mutationSettore MED/03 - Genetica MedicaCodon NonsenseLipoid Proteinosis of Urbach and WietheSettore MED/26 - NeurologiaFemaleBritish Journal of Dermatology
researchProduct

Ocular surface disease during dupilumab treatment in patients with atopic dermatitis, is it possible to prevent it?

2020

medicine.medical_specialtyInterleukin-13Ocular surface diseasebusiness.industryMEDLINEEczemaDermatologyAtopic dermatitismedicine.diseaseAntibodies Monoclonal HumanizedDupilumabDermatologyDermatitis Atopicdupilumab atopic dermatitis ocular surface diseaseInfectious DiseasesmedicineHumansIn patientbusinessJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct

Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis

2008

Psoriasis and psoriatic arthritis are common diseases associated with considerable morbidity and disability. Their pathophysiology comprises similar processes leading to inflammation of skin, entheses, and joints. Although traditional systemic agents can be effective, their use may be limited by lack of efficacy and concerns regarding adverse effects. The objective of this study was to assess the efficacy and safety of adalimumab, a fully human antitumor necrosis factor (anti-TNF) monoclonal antibody, over 16 weeks. The present authors report their personal experience in 15 patients with severe plaque psoriasis and psoriatic arthritis, refractory to other treatments, in which a decisive reg…

AdultMalemedicine.medical_specialtyAnti-Inflammatory AgentsArthritisDermatologyAntibodies Monoclonal HumanizedSeverity of Illness IndexPsoriasis Psoriatic ArthritisPsoriatic arthritisPsoriasisSeverity of illnessSettore MED/35 - Malattie Cutanee E VenereemedicineAdalimumabHumansPsoriasisAdverse effectTumor Necrosis Factor-alphabusiness.industryArthritis PsoriaticAdalimumabAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseDermatologyRadiographyClinical trialTreatment OutcomeMonoclonalFemalebusinessmedicine.drugDermatologic Therapy
researchProduct

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

2020

ObjectiveCancer stem cells are responsible for tumour spreading and relapse. Human epidermal growth factor receptor 2 (HER2) expression is a negative prognostic factor in colorectal cancer (CRC) and a potential target in tumours carrying the gene amplification. Our aim was to define the expression of HER2 in colorectal cancer stem cells (CR-CSCs) and its possible role as therapeutic target in CRC resistant to anti- epidermal growth factor receptor (EGFR) therapy.DesignA collection of primary sphere cell cultures obtained from 60 CRC specimens was used to generate CR-CSC mouse avatars to preclinically validate therapeutic options. We also made use of the ChIP-seq analysis for transcriptional…

0301 basic medicineReceptor ErbB-2Colorectal cancerCetuximabcolorectal cancermedicine.disease_cause03 medical and health sciencesAntineoplastic Agents Immunological0302 clinical medicineSettore MED/04 - PATOLOGIA GENERALECancer stem cellstem cellsTumor Cells CulturedmedicineAdjuvant therapyAnimalsHumansEpidermal growth factor receptorProtein kinase BPI3K/AKT/mTOR pathwayPhosphoinositide-3 Kinase InhibitorsMitogen-Activated Protein Kinase Kinasesdrug resistancebiologybusiness.industryGastroenterologyTrastuzumabmedicine.diseaseantibody targeted therapy030104 developmental biologyDrug Resistance Neoplasm030220 oncology & carcinogenesisNeoplastic Stem CellsCancer researchbiology.proteinKRASPhosphatidylinositol 3-KinaseStem cellColorectal Neoplasmsbusiness
researchProduct

Achilles tendon ultrasonography may detect early features of psoriatic arthropathy in patients with cutaneous psoriasis.

2014

SummaryBackground Psoriatic arthropathy is a progressive and debilitating disease involving reduction of functional activity of the articulations with consequent deterioration of the patient's quality of life. The entheses represent the initial site of articular inflammation and the enthesis of the Achilles tendon is the first to be affected. In some patients with psoriasis, enthesitis may not be diagnosed because it is still asymptomatic. Objectives To evaluate whether ultrasonography allows early diagnosis in a larger population and to identify significant alterations of enthesitis beyond increased thickness of the Achilles tendon. Materials and methods The study was undertaken on 59 pati…

AdultMalemedicine.medical_specialtyHeelBursitisPopulationDermatologyAchilles TendonYoung AdultPsoriasismedicineHumansPsoriasiseducationAgedUltrasonographyAchilles tendoneducation.field_of_studybusiness.industryArthritis PsoriaticEnthesitisMiddle Agedmedicine.diseaseEnthesisDermatologyTendonSurgerymedicine.anatomical_structureEarly DiagnosisTendinopathyFemalemedicine.symptombusinessThe British journal of dermatology
researchProduct

Update on the Management of Pediatric Psoriasis: An Italian Consensus

2022

Introduction Psoriasis affects children with a considerable burden in early life. Treating pediatric psoriasis is challenging also because of the lack of updated specific guidelines. With the recent approval of several biologics for pediatric psoriasis and the ongoing COVID-19 pandemic, the management of young psoriatic patients is facing major changes. A revision of treatment recommendations is therefore needed. Methods In September 2021, a board of six Italian dermatologists convened to update treatment recommendations. The board issued evidence- and consensus-based statements covering relevant areas of pediatric psoriasis, namely: assessment of psoriasis severity, management of children …

Topical corticosteroidsAdolescentBiologicSystemic therapyCorticosteroid-sparingHealth-related quality of lifePediatric psoriasisDermatologyBiologicsAdolescentsPlaque psoriasiAdolescents; Biologics; Children; Corticosteroid-sparing; Health-related quality of life; Pediatric psoriasis; Plaque psoriasis; Systemic therapy; Topical corticosteroidsSettore MED/35Pediatric psoriasiPlaque psoriasisSettore MED/35 - MALATTIE CUTANEE E VENEREEChildren
researchProduct

Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.

2011

Although no study has definitively shown that unfocused screening of skin cancer is effective, many campaigns have been organized with the aim of increasing awareness on melanoma risk factors. The objective of this study was to analyse the results of the Skin Cancer Screening Day in Italy during the period 2005-2007, to determine the priorities for melanoma control plans in a Mediterranean country. A total of 5002 patients were screened by dermatologists in 31 cities. Individuals who considered themselves to have many naevi and those with a family history of melanoma showed a higher number of common and atypical naevi. Ten melanomas, 20 basal cell carcinomas and two squamous cell carcinomas…

Program evaluationMaleCancer ResearchSkin NeoplasmsTime FactorsEpidemiologyBasal CellpreventionRisk Factorsself-surveillance80 and overSettore MED/35 - Malattie Cutanee E VenereeMedicineMass Screeningmelanoma screening campaignMelanoma prevention strategy Melanoma risk factors Melanoma screening campaign Self-surveillance Skin cancerFamily historyYoung adultChildMelanomaAged 80 and overeducation.field_of_studyNevus Pigmentedskin cancerMelanomaMiddle AgedMALIGNANT MELANOMA; screeningPrognosisOncologyItalymelanoma; screening; risk factors; prevention; prognosisChild PreschoolCarcinoma Squamous CellFemaleAdultmedicine.medical_specialtyAdolescentPopulationmelanoma prevention strategy; melanoma risk factors; melanoma screening campaign; self-surveillance; skin cancermelanoma prevention strategyYoung AdultPigmentedHumansmelanoma prevention strategy; melanoma risk factors; melanoma screening campaign; skin cancer; self-surveillancePreschooleducationNevusSocioeconomic statusMass screeningAgedbusiness.industrymelanoma risk factorsscreeningCarcinomaPublic Health Environmental and Occupational Healthmelanoma risk factorInfantmedicine.diseaseDermatologyMALIGNANT MELANOMASquamous CellCarcinoma Basal CellSelf-ExaminationSkin cancerbusinessProgram Evaluation
researchProduct

Lengthening the time intervals between doses of dupilumab in remission atopic dermatitis

2023

Infectious Diseasesatopic dermatitis dupilumab therapyDermatology
researchProduct

Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery.

2021

Obesity is a strong risk factor for cancer progression, posing obesity-related cancer as one of the leading causes of death. Nevertheless, the molecular mechanisms that endow cancer cells with metastatic properties in patients affected by obesity remain unexplored. Here, we show that IL-6 and HGF, secreted by tumor neighboring visceral adipose stromal cells (V-ASCs), expand the metastatic colorectal (CR) cancer cell compartment (CD44v6 + ), which in turn secretes neurotrophins such as NGF and NT-3, and recruits adipose stem cells within tumor mass. Visceral adipose-derived factors promote vasculogenesis and the onset of metastatic dissemination by activation of STAT3, which inhibits miR-200…

MaleCancer microenvironmentobesityStromal cellColorectal cancerScienceSettore MED/50 - Scienze Tecniche Mediche ApplicateGeneral Physics and AstronomyAdipose tissueMice SCIDSCIDmetastasis.General Biochemistry Genetics and Molecular BiologyArticleMiceVasculogenesisSettore MED/04 - PATOLOGIA GENERALEmedicineAnimalsHumansNeoplasm MetastasisStem Cell NicheZinc Finger E-box Binding Homeobox 2Tumor microenvironmentMultidisciplinarybusiness.industryHepatocyte Growth FactorInterleukin-6Stem CellsQadipose stromal cellCancerCD44v6General Chemistrymedicine.diseaseCellular ReprogrammingColorectal cancerMicroRNAsAdipose TissueCancer cellColonic NeoplasmsCancer researchNeoplastic Stem Cellsconsensus molecular subtypeStem cellSettore MED/46 - Scienze Tecniche Di Medicina Di LaboratoriobusinessNature communications
researchProduct

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

2020

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is creating an unprecedented global public health emergency with the continuous growth of infected individuals worldwide. Italy was one of the first European country to face the first wave of infection outside mainland China. The first case of COVID-19 was confirmed in Lombardy on February 20th , 2020, and subsequently, a rapid increase in the number of detected cases was observed, spreading through Italy and the rest of Europe.3 As of April 22nd , confirmed COVID-19 cases in Italy were 183,957.

medicine.medical_specialtyTildrakizumabBiolgical therapy; COVID-19; PsoriasisSettore MED/35PsoriasisChronic Disease; Emergencies; Humans; Italy; Psoriasis; Biological Therapy; COVID-19UstekinumabmedicineAdalimumabHumansPsoriasisbiologicsIntensive care medicineLetter to the Editorpsoriasipsoriasis; biologics; covid-19; pandemicEmergenciePsoriasiRisankizumabbusiness.industrySARS-CoV-2pandemicBiolgical therapyCOVID-19medicine.diseasedermatologyBiological TherapyIxekizumabGuselkumabInfectious Diseasescovid-19ItalyChronic DiseaseSecukinumabEmergenciesbusinessSettore MED/35 - MALATTIE CUTANEE E VENEREEbiologicCOVID-19 psoriasis biological therapiesmedicine.drugHuman
researchProduct

Malattia di Urbach-Wiethe

2005

researchProduct

Angiokeratoma: decision-making aid for the diagnosis of Fabry disease

2012

Isolated angiokeratomas are common benign cutaneous lesions, generally deemed unworthy of further investigation. In contrast, diffuse angiokeratomas should alert the physician to a possible diagnosis of Fabry disease, a rare X-linked lysosomal storage disorder, characterized by a-galactosidase deficiency. Glycosphingolipids accumulate in cells throughout the body resulting in progressive multi-organ failure. Difficulties are encountered when trying to interpret the significance of angiokeratomas because they may also occur in other lysosomal storage disorders and rarely in an isolated manner in Fabry disease. We present an algorithm for the classification of angiokeratomas which might prove…

angiokeratomasFabry diseaseFabry's diseaseSettore MED/09 - MEDICINA INTERNASettore MED/35 - MALATTIE CUTANEE E VENEREE
researchProduct

Leishmaniosi Cutanea

2008

Settore MED/35 - Malattie Cutanee E VenereeLeishmaniosi Cutanea
researchProduct

Sarcoma di Kaposi

2004

researchProduct

ECZEMA MAMMARIO E DELLA REGIONE VULVARE

2007

researchProduct

The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in …

2017

Introduction: Female sex has been shown to be a risk factor for the development of adverse drug reactions; however, this has not been studied for cyclosporine (CsA). The aim of this study was to investigate, in Italian dermatological practice, the influence of gender and menopause and related hormones on the incidence of adverse events (AEs) during CsA treatment in psoriatic patients. Methods: Multicenter, prospective, observational study conducted from May 2011 to June 2013. Patients with plaque psoriasis, undergoing a new CsA administration course, or about to start it, were enrolled in the outpatient clinics of Italian dermatological centers. During the 2–6 months of study duration, pati…

MaleSex FactorRate ratio030226 pharmacology & pharmacyGonadal Steroid HormoneSeverity of Illness Index0302 clinical medicineOutpatient clinicAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; PsoriasisPharmacology (medical)030212 general & internal medicineProspective StudiesProspective cohort studyGonadal Steroid HormonesOriginal ResearchIncidence (epidemiology)IncidenceMedicine (all)General MedicineMiddle AgedMenopausePostmenopauseItalyCyclosporineFemaleSettore MED/35 - MALATTIE CUTANEE E VENEREEHumanAdultmedicine.medical_specialtyAdolescentAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; Psoriasis; Adolescent; Adult; Cyclosporine; Female; Gonadal Steroid Hormones; Humans; Incidence; Italy; Male; Middle Aged; Postmenopause; Prospective Studies; Psoriasis; Severity of Illness Index; Sex Factors; Young Adult; Pharmacology (medical)Adverse drug reactionDermatology03 medical and health sciencesYoung AdultSex FactorsInternal medicineSeverity of illnessmedicineHumansPsoriasisRisk factorAdverse effectPsoriasibusiness.industryGendermedicine.diseaseSurgeryAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; Psoriasis; Medicine (all); Pharmacology (medical)Prospective StudiebusinessAdverse drug reaction; Cyclosporine; Dermatology; Female; Gender; Psoriasis;
researchProduct

Dal melanocita al melanoma

2005

researchProduct

Le cellule CD34 nel sarcoma di Kaposi

2005

researchProduct

destructive cutaneous leishmaniasis in a patient being treated with anti-tumour necrosis factor-a

2014

Settore MED/35 - Malattie Cutanee E Venereeleishmaniasis
researchProduct

The Italian Euromelanoma Day: evaluation of results and implications for future prevention campaigns.

2012

Background Melanoma incidence/mortality is increasing worldwide. “Euromelanoma Day” is a pan-European campaign for skin cancer prevention. Results of the 2010 Euromelanoma Day in Italy are reported herein. Materials and methods A questionnaire was used to collect data on participants' characteristics and suspected skin cancers. Result A total of 1085 participants was screened (64.1% females, median age 44 years). Suspicion rate, detection rate, and positive predictive values for melanoma were 1.3, 0.28 and 21.4%, respectively. Poorly educated, ≥35 years old, pale-skinned males were at higher risk for skin cancer than highly educated, <35 years old, darker-skinned females, although the latte…

MaleQuestionnairesPediatricsSkin NeoplasmsHealth BehaviorSurveys and Questionnairesinglese80 and overSettore MED/35 - Malattie Cutanee E VenereeMass ScreeningMedicineSkin cancerYoung adultChildMelanomaEarly Detection of CancerAged 80 and overintegumentary systemIncidence (epidemiology)Middle AgedDay screening campaignPredictive valueEuropeItalyChild PreschoolSunlightFemaleRisk assessmentCutaneous malignant melanomaAdultmedicine.medical_specialtyAdolescentDay screening campaign; Skin cancer; Cutaneous malignant melanomaDermoscopyHealth PromotionDermatologyRisk AssessmentYoung AdultHumansPreschoolMass screeningAgedbusiness.industrymedicine.diseaseSurgeryMelanoma detectionAnniversaries and Special EventsHealth promotionSkin cancerbusinessProgram Evaluation
researchProduct

Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.

2010

BACKGROUND: One of the major goals of pemphigus therapy is to reduce the patient's cumulative exposure to systemic corticosteroids. To investigate the efficacy of enteric-coated mycophenolate sodium (EC-MPS), 10 patients with active, refractory pemphigus vulgaris (PV) or foliaceous (PF) were treated with EC-MPS (1440 mg daily) and prednisone (75 mg daily) over 18 months. OBSERVATIONS: Following EC-MPS/prednisone therapy, disease progression was inhibited between days 30 and 45 in 9/10 patients (8 PV; 1 PF). At 18 months, 8/9 PV patients had clinically quiescent disease; EC-MPS therapy was no longer required in two patients as a result of disease remission. The remaining PV patient showed no…

AdultMaleAdministration OralMiddle AgedMycophenolic AcidTreatment OutcomeSettore MED/35 - Malattie Cutanee E VenereeEnteric-coated Mycophenolate SodiumHumansPrednisoneDrug Therapy CombinationFemaleTablets Enteric-CoatedGlucocorticoidsImmunosuppressive AgentsPemphigusFollow-Up StudiesInternational journal of dermatology
researchProduct

Lentigo maligna melanoma: esperienza clinica e immunoistochimica.

2007

researchProduct

BEXAROTENEE MICOSI FUNGOIDE

2012

MICOSI FUNGOIDE BEXAROTENE
researchProduct

Imiquimod e lesioni vascolari.

2006

researchProduct

Follicular mycosis fungoides. a clinicopathological, and immunohistochemical study of two cases

2004

researchProduct

Aspetti patogenetici del sarcoma di kaposi

2005

researchProduct

Ulcere cutanee

2007

researchProduct

Sifilide

2004

researchProduct

Infezione cutanea

2005

researchProduct

Reflectance mode confocal microscopy and digital image analysis in naevus of Hori and pathogenetic evaluation

2012

Settore MED/35 - Malattie Cutanee E VenereeReflectance mode confocal microscopy
researchProduct

Dermoscopia Dei Nevi Melanocitari In Particolari Sedi Acrali

2005

Dermoscopia Nevi Melanocitari
researchProduct

La sifilide: aspetti attuali.

2006

researchProduct

MALATTIE INFETTIVE DI INTERESSE DERMATOLOGICO IN GRAVIDANZA.

2007

researchProduct

La malattia di Anderson-Fabry

2009

Malattia di Anderson-FabrySettore MED/35 - Malattie Cutanee E Veneree
researchProduct

LEISHMANIOSI CUTANEA ATIPICA

2007

researchProduct

Ulcere: patogenesi e terapia.

2006

researchProduct

Linfedema-Elefantiasi

2009

LinfedemaElefantiasiSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

The prevalence of the obesity in patients with moderate to severe psoriasis in Sicily populations

2009

psoriasis obesitySettore MED/35 - Malattie Cutanee E Veneree
researchProduct

Dermatosi pustolose amicrobiche e dermatosi neutrofiliche

2007

researchProduct

MANIFESTAZIONI VULVARI IN CORSO DI MALATTIE SISTEMICHE

2007

researchProduct

Patogenesi Del Sarcoma Di Kaposi

2005

Sarcoma Di KaposiSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry

2013

Objective To evaluate variations in laboratory parameters and diagnoses of selected clinical conditions up to 16 weeks after starting a new systemic psoriasis treatment for Psocare Registry enrollees. Design Prospective cohort study. Setting Italian public referral centres for psoriasis treatment. Patients First-time recipients (n = 10,539) of continuous systemic psoriasis treatment for at least 16 weeks. Main outcome measure Mean variations in (weeks 8 and 16) and proportions of patients reaching a clinically meaningful increase in serum levels (week 16) of total and low-density lipoprotein cholesterol, triglycerides, aspartate amino transferase, alanine amino transferase and creatinine, a…

Settore MED/35 - Malattie Cutanee E VenereePSORIASISTHERAPY
researchProduct

I Difetti Congeniti Della Pigmentazione

2008

I Difetti Congeniti Della PigmentazioneSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

Lentigo Maligna:Un Approccio Concreto

2008

Lentigo MalignaSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

TEST-AND-TREAT ANCHE PER LA POPOLAZIONE GERIATRICA CON HP-INFEZIONE?

2008

helicobacter pylori HP-infezione test and treat
researchProduct

Le infezioni in corso di terapia anti- TNF alfa

2012

Anti TNF-alfa infezioni leishmaniosi cutanea
researchProduct

Terapia Enzimatica Sostitutiva Della Malattia Di Fabry:Due Anni Di Esperienza

2004

Settore MED/35 - Malattie Cutanee E VenereeMalattia Di Fabry
researchProduct

Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry

2021

Abstract Background Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID‐19) pandemic. Methods A national registry, named DA‐COVID‐19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID‐19 pandemic on the management of adult AD patients treated with systemic immunomodulant/immunosuppressive medications or phototherapy. Demographic and clinical data were obtained at different timepoints by teledermatology during COVID‐19 pandemic, when regular visits were not allowed due to sanitary restrictions. Disease severi…

Registrie0301 basic medicineDermatitisSystemic therapy0302 clinical medicinePandemicImmunology and AllergyMedicineRegistriesatopic dermatitis; COVID; SARS‐ CoVCOVIDtreatmentatopic dermatitisatopic dermatitis; COVID; SARS-CoVSARS-CoVAtopic dermatitisDupilumabSARS‐ CoVItalyOriginal ArticleSettore MED/35 - MALATTIE CUTANEE E VENEREEHumanatopic dermatitiAdultmedicine.medical_specialtyTeledermatologyCOVID; SARS‐CoV; atopic dermatitis treatmentCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCOVID; SARS‐CoV; atopic dermatitis; Adult; Communicable Disease Control; Humans; Italy; Pandemics; Registries; SARS-CoV-2; COVID-19; Dermatitis AtopicAtopicDermatitis Atopic03 medical and health sciencesSettore MED/35Disease severityInternal medicineatopic dermatitis treatmentHumansPandemicsPandemicbusiness.industrySARS-CoV-2SARS‐CoVCOVID-19medicine.disease030104 developmental biology030228 respiratory systemCommunicable Disease Controlatopic dermatitis; COVID; SARS-CoV; Adult; Communicable Disease Control; Humans; Italy; Pandemics; Registries; SARS-CoV-2; COVID-19; Dermatitis Atopicatopic dermatitis COVID SARS-CoVbusiness
researchProduct

Melanoma

2006

researchProduct

Dermatosi Vasculo-Dipendenti Delle Estremità

2009

Settore MED/35 - Malattie Cutanee E VenereeDermatosi Vasculo-Dipendenti
researchProduct

Lupus eritematoso:istopatologia

2004

researchProduct

Ulcera Da Pressione E Gangrena

2009

Ulcera Da Pressione GangrenaSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

The effects of inositol in the female androgenetic alopecia: preliminary data

2014

inositol androgenetic alopeciaSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

PSEUDOXANTHOMA ELASTICUM

2007

researchProduct

Melanoma Oculare

2008

melanoma occhio congiuntivaSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

Aspetti istopatologici e fenotipici del sarcoma di Kaposi

2005

researchProduct

Chiazze rosa-fucsia diffuse in giovane paziente

2012

pseudocromatosi
researchProduct

Aspetti eziologici del Sarcoma di Kaposi

2004

researchProduct

Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab The…

2022

N/A

Dupilumab TherapyAntibodies Monoclonal Humanized; Disease Progression; Humans; Treatment Outcome; COVID-19; Dermatitis AtopicDermatitisAtopic dermatitis.DermatologyDupilumabAntibodies Monoclonal HumanizedAntibodiesAtopicDermatitis AtopicSettore MED/35MonoclonalImmunology and AllergyHumanshumanHumanizedAtopic dermatitistreatment outcome Antibodies Monoclonal HumanizedCOVID-19Treatment OutcomeCOVID-19 Dupilumab Therapydisease exacerbationDisease ProgressionSettore MED/35 - MALATTIE CUTANEE E VENEREEHumanmonoclonal antibody atopic dermatiti
researchProduct

TERAPIA BIOLOGICA CON ETANERCEPT IN UN UOMO DI 51 ANNI AFFETTO DA PSORIASI REFRATTARIA : ESPERIENZA E VALUTAZIONE CLINICA

2005

researchProduct

onychogryphosis an the quality of life

2007

researchProduct

Norwegian (crusted) scabies of glans penis in an immunocompetent patien

2009

Norwegian (crusted) scabiesSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

MALATTIE TRASMESSE SESSUALMENTE: BATTERICHE E PROTOZOARIE

2007

researchProduct

Melanoma della congiuntiva

2006

researchProduct

IMPETIGO HERPETIFORMIS

2007

researchProduct

Panniculiti

2009

Settore MED/35 - Malattie Cutanee E VenereePanniculiti
researchProduct

Studio retrospettivo sulla variazione nel tempo dell’indice di Breslow in una casistica multicentrica di pazienti con melanoma cutaneo

2009

Settore MED/35 - Malattie Cutanee E Venereemelanoma cutaneo epidemiologia
researchProduct

Terapia delle malattie sessualmente trasmesse in gravidanza.

2006

researchProduct

Aspetti etiopatogenetici del sarcoma di Kaposi

2006

researchProduct

Malattia di Darier

2006

researchProduct

Neurofibromatosis of the nipple-areolar area : nine case reports

2010

Introduction: Neurofibromatosis type 1 is an autosomal dominant disorder that occurs across all ethnic groups and affects approximately one in 4000 individuals. One of the most noticeable characteristics of the disease is the development of neurofibromas. Case presentation: A total of 258 patients (131 women, 127 men) with neurofibromatosis type 1 were evaluated between 1994 and 2004 in our hospital's dermatology department. Nine patients (3.45%, 95% confidence limits 1.22 to 5.68) had neurofibromas of the breast. One of these nine patients presented with an extensive congenital plexiform neurofibroma in the outer quadrants of her right breast, extending to the nipple-areolar complex. Meanw…

Settore MED/35 - Malattie Cutanee E Venereebreast nipple-areolar areaplexiform neurofibromaneurofibromatosis type 1neurofibroma
researchProduct

AGE6. Skin Ageing: Focus on the Role of Inflammatory Genetic Factors in Cutaneous Neoplasia

2014

AGE6. Skin Ageing: Focus on the Role of Inflammatory Genetic Factors in Cutaneous Neoplasia C. M. Gambino1, F. Crapanzano1, G. Accardi1, A. Aiello1, C. Virruso1, G. Pistone1, M. R. Bongiorno1, D. Lio1, C. R. Balistreri1, G. Candore1 1University of Palermo, Palermo, Italy Background: Skin aging is a complex process that involves intrinsic and exogenous causes. Photo-oxidative damage caused by UV is the leading cause of extrinsic aging of the skin, known as photo-ageing. UV damages can be linked mostly to overproduction of ROS that induces a complex molecular cascade able to accelerate physiological aging, determining a typical dermal/epidermal inflammation with an increased risk of getting s…

rs.4986790) TLR4 (+1196 C/T rs.4986791) MMP2 (-1306 C/T rs.243865) and MMP9 (-1562 C/T rs.3918242)SNPsSkin aging TLR4 (+896 A/G; rs.4986790) TLR4 (+1196 C/T rs.4986791) MMP2 (-1306 C/T rs.243865) and MMP9 (-1562 C/T rs.3918242)SNPsSkin aging TLR4 (+896 A/G
researchProduct

Cute e diabete

2004

researchProduct

La gonorrea oggi

2013

malattie sessualmente trasmesse gonorreaSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic. risk analysis from the PSO-BIO-COVI…

2021

Background The susceptibility of patients with chronic plaque psoriasis and the risks or benefits related to the use of biological therapies for COVID-19 are unknown. Few data about prevalence, clinical course and outcomes of COVID-19 among psoriatic patients were reported. The aims of this study were 1) to assess the prevalence and severity of COVID-19 in psoriatic patients treated with biologic agents during the first phase of the emergency (22 February to 22 April 2020) in Italy, and 2) to report the clinical outcomes of patients who have been exposed to individuals with confirmed SARS-CoV-2 infection. Methods Patients with moderate-to-severe chronic plaque psoriasis, aged ≥18 years and …

0301 basic medicineMaleClinical BiochemistryDiseaseCohort Studies0302 clinical medicineDrug DiscoveryReceptors80 and overMedicineAged 80 and overeducation.field_of_studyIncidence (epidemiology)IncidenceInterleukin-17psoriasisMiddle Ageddermatologysars-CoV-2Italybiological therapy030220 oncology & carcinogenesisCohortBiological ProductCOVID-19; biological therapy; dermatology; psoriasis; sars-CoV-2FemaleSettore MED/35 - MALATTIE CUTANEE E VENEREEbiological therapy; COVID-19; dermatology; psoriasis; sars-CoV-2; Adult; Aged; Aged 80 and over; Biological Products; Biological Therapy; COVID-19; Chronic Disease; Cohort Studies; Female; Humans; Incidence; Interleukin-17; Italy; Male; Middle Aged; Pandemics; Psoriasis; Receptors Interleukin; Risk Assessment; Tumor Necrosis Factor-alpha; Young AdultCohort studyHumanAdultmedicine.medical_specialtyPopulationRisk AssessmentCOVID-19; psoriasis; biological therapy; dermatology; sars-CoV-203 medical and health sciencesYoung AdultSettore MED/35Internal medicinePsoriasisPsoriasis.HumanseducationPandemicsAgedPharmacologyPsoriasiBiological ProductsPandemicbiological therapy; COVID-19; dermatology; psoriasis; sars-CoV-2business.industryTumor Necrosis Factor-alphaCOVID-19Receptors InterleukinBiological productInterleukinmedicine.diseaseClinical trial030104 developmental biologyChronic DiseaseCOVID-19; SARS-CoV-2; biological therapy; dermatology; psoriasisCohort Studiebusiness
researchProduct

Allergic contact dermatitis with contact urticaria to colophony from an alternative remedy.

2012

Allergic contact dermatitialternative remedySettore MED/35 - Malattie Cutanee E Venereecolophonycontact urticaria
researchProduct

Clinica: Aspetti Clinici, Classificazione, Varianti Cliniche

2008

Settore MED/35 - Malattie Cutanee E Venereemelanoma clinica classificazione
researchProduct

Exogenous ochronosis and striae atrophicae following the use of bleaching creams.

2005

Exogenous ochronosis is a paradoxical hyper-pigmentation of the skin caused by the long-term use of hydroquinone-containing bleaching creams. Ochronosis is an uncommon condition characterized by yellow-brown pigmented deposits in the dermis. We report two cases of exogenous ochronosis in two female patients of the sub-Saharan African population. The lesions were characterized by an asymptomatic hyper-pigmentation of the face with gradually progressive blue-black macular patches, and in case no. 2, in addition to dyschromic lesions, striae atrophicae were present. This phenomenon is the outcome of the use of skin care products containing high concentrations of hydroquinone- and glucocorticoi…

Pathologymedicine.medical_specialtyDermatology.DermisHyperpigmentationFemale patientmedicineHumansGlucocorticoidsPigmentation disorderStriae atrophicaeSkinSkin careOchronosisExogenous ochronosisbusiness.industryMiddle Agedmedicine.diseaseHydroquinonesmedicine.anatomical_structureAfrican populationFemalesense organsDermatologic AgentsAtrophybusinessOchronosisInternational journal of dermatology
researchProduct

Lichen planus orale

2009

Lichen planus oraleSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

PSORIASI INVERSA

2007

researchProduct

Achilles tendon ultrasonography may detect early features of psoriatic arthropathy in those with cutaneous psoriasis

2014

Settore MED/35 - Malattie Cutanee E Venereepsoriatic arthropathyAchilles tendon
researchProduct

The immunoexpression of matrix metalloproteinase MMP2 and MMP9 as prognostic significance in cutaneous metastases of breast carcinoma

2004

Aim. Many types of cutaneous metastasis occur in carcinoma of the breast. Cutaneous metastasis has been reported as having a poor prognosis. A fundamental prerequisite for carcinoma cells to metastatize is the ability of the tumour cells to dissociate from the primary tumour and to breach matrix proteins. Degradation and remodelling of matrix proteins can be affected by a variety of enzymatic activities including the matrix metalloproteinases (MMPs). We have analysed the sensitivity, specificity and predictive value of immunohistochemical staining with monoclonal antibodies directed against gelatinase A (MMP-2) and B (MMP-9) in cutaneous metastatic breast carcinoma. Methods. Twenty-two pati…

Gelatinase ABreast neoplasmMetalloproteinase 9Gelatinase BSkin neoplasmsMetalloproteinase 2
researchProduct

LENTIGO MALIGNA MELANOMA

2008

researchProduct

idiopathic acquired leukonichia in a 34 year-old patient

2007

researchProduct

[Fabry disease in Italy: first epidemiologic and collaborative study].

2005

The authors sought to define the prevalence of Fabry disease and to establish the incidence and its natural history in Italy. The aim of this study was to point out the first clinical signs and symptoms to perform an early diagnosis and hence to start a specific therapeutic treatment. Fabry disease is an inborn error of metabolism caused by the deficiency of the lysosomal enzyme alpha-galactosidase A. Fabry disease is a severe X-linked disorder presenting with a higher morbidity between the third and the fourth decade of life. Fabry disease may be confused with other diseases or completely misdiagnosed: its frequency is estimated worldwide to be 1:117000. In Italy, 65 patients have been ide…

AdultDiagnosis DifferentialMaleAdolescentItalyalpha-GalactosidaseFabry DiseaseHumansFemaleAlgorithms
researchProduct

Suspected cutaneous leishmaniasis in a sample of Western Sicily residents: what correlation with occupation?

2017

Background: Leishmaniasis is a widespread infectious disease, but there is not much information about its prevalence in high risk occupational categories. Objectives: Te aim of this study is to assess the prevalence of Leishmania immunological positivity in human skin tissues collected from subjects living in Western Sicily, with suspected cutaneous Leishmania infection, in order to explore the risk possibly related to occupation. Methods: 318 consecutive subjects (M/F ratio=1.0, mean age=40±25.4 years), attending the Dermatology Department of the University of Palermo Hospital from 2013 to 2015, without any previous history of Leishmania infection and performing various occupations, were i…

Cutaneous leishmaniasis; Leishmania infantum; work-related leishmaniasis; climate changeclimate changeSettore MED/44 - Medicina Del LavoroCutaneous leishmaniasiwork-related leishmaniasiLeishmania infantum
researchProduct

LE INFEZIONI IN CORSO DI TERAPOIA ANTI TNF-ALFA

2012

INFEZIONI FARMACI ANTI TNF-ALFA
researchProduct

Melanoma Delle Sedi Speciali (Mucose, Subungueale, Plantare)

2008

mucose subungueale plantare
researchProduct

[Cardiovascular risk profile of patients with psoriasis].

2013

The aim of this study was to assess the cardiovascular risk profile of patients with psoriasis compared to patients without psoriasis. A case-control assay was performed using 143 cases (psoriasis patients) and 104 controls (patients without psoriasis). We assessed the presence of hypertension, lipid profile (HDL, triglycerides), diabetes, and body mass index in both cases and controls. Psoriasis patients showed an unfavorable cardiovascular risk profile and a higher risk of cardiovascular events and metabolic syndrome than patients without psoriasis.

Cardiovascular risk psoriasis
researchProduct

CONNETTIVOPATIE IN GRAVIDANZA

2007

researchProduct

Simultaneous diagnosis of Kaposi’s sarcoma, psoriasis,vitiligo and monoclonal gammopathy of undetermined significance in an immunocompetent patient

2013

Kaposi’s sarcoma psoriasis vitiligo and monoclonal gammopathy of undetermined significanceSettore MED/35 - Malattie Cutanee E Veneree
researchProduct

La psoriasi eziopatogenesi ed epidemiologia

2005

researchProduct

La Sclerosi tuberosa aspetti clinici ed istopatologici.

2005

researchProduct

Aspetti Clinici, Classificazione, Varianti Cliniche

2008

Settore MED/35 - Malattie Cutanee E VenereeMELANOMA
researchProduct

ONICOPATIA PSORIASICA

2007

researchProduct

La Malattia Di Anderson –Fabry

2008

Settore MED/35 - Malattie Cutanee E VenereeMalattia Di Anderson –Fabry
researchProduct

Sindrome di Gorlin-Gotz

2004

researchProduct